NFOG 2008 XXXVI Congress of the Nordic Federation of Societies of and Gynecology

June 14th–17th 2008, Reykjavík Iceland

PROGRAMME AND ABSTRACTS

www.nfog2008.is Dear colleagues, welcome to Reykjavík!

The 36th NFOG congress has commenced and many people deserve thanks for making this possible. Our federation, NFOG, plays an important role in bringing us together in events such as this congress and in helping us keep up our professional standards. During the next three days we are offered a great variety of lectures in all fields of Obstetrics and Gynecology. We are honoured by the outstanding speakers from the Nordic Societies and from both sides of the Atlantic. In addition to six plenary lectures, the NFOG symposium is a plenary on the global perspective of women´s health. At all other times, four concurrent symposia will be ongoing so everyone should find something of interest.

It is a special pleasure to welcome our keynote speaker Dr. Dorothy Shaw, President of FIGO (Fédération Internationale de Gynécologie et Obstétrique). This gives us a valuable opportunity to listen to the leading voice of FIGO, whose mission is to promote women´s health and safe motherhood and to raise the standards of practice in Obstetrics and Gynecology around the world.

On behalf of the local organizing committee and the NFOG Board, I warmly welcome you to this congress in Reykjavík, the capital city of Iceland, and hope that you will enjoy the scientific programme of the congress as well as the social events. Hopefully you will also have an opportunity to experience Icelandic culture and nature.

Yours sincerely, Þóra Steingrímsdóttir Congress president

Picture on cover: Artist: Eggert Pétursson (b.1956). Untitled 2004–2005. Oil on canvas. The picture is a small part of the painting which shows the national flower “Holtasóley” (e; mountain avens, latin; dryas octopetala). The real size is 170x170cm. This piece of art is owned by Landsbanki who kindly gave permission to have the painting on display at Háskólabíó during the NFOG congress. The NFOG congress committee would like to express their gratitude to Landsbanki for their generous support.

About the artist: Eggert Petursson’s sole subject is the Icelandic flora. Conceptual rather than decorative, his unique paintings of the minute tundra flowers of Iceland’s seemingly barren landscape reveal, with dizzying effect, the universe within. Abstract at a distance, at close inspection his canvases are hyper-realistic – an infinite regression of painstaking brush detail creating each petal, stem and leaf. PRENTSNIÐ – LETURPRENT Index

Welcome ...... 1 Scientific committee...... 4 Local organizing committee ...... 4 Summary of NFYOGs activities 2007 ...... 5 NFOG National Societies ...... 5 Programme overview ...... 6 Social programme ...... 13 General information...... 15 Programme ...... 17 Map of the congress venue Háskólabíó...... 44 Abstracts invited speakers ...... 47 Free communications ...... 85 Posters ...... 111 Author index...... 153 Scientific committee Thue Bryndorf, Denmark Oskari Heikinheimo, Finland Alexander Smárason, Iceland Knut Hordnes, Norway Lars-Åke Mattsson (chairperson), Sweden

Local organizing committee Þóra Steingrímsdóttir, president Ósk Ingvarsdóttir, secretary general Alexander Smárason, scientific secretary Ólafur M Håkansson, treasurer Arnar Hauksson, industry – sponsors Ragnheiður Ingibjörg Bjarnadóttir Reynir Tómas Geirsson Dögg Hauksdóttir, NFYOG member Hildur Harðardóttir Jens A Guðmundsson

4 NFOG 2008 Summary of NFYOGs activities 2007 The NFYOG board 2007 consisted of 10 members, 2 from each of the Nordic countries Denmark, Sweden, Finland, Iceland and Norway. Three board meetings were held. The spring meeting was held in Helsinki where the final touches to the Copenhagen seminar 2007 “Is there a future for obstetrics?” were made. The Copenhagen seminar “Is there a future for obstetrics?” was held in the Novonordisk conference facilities in Copenhagen on June 1st and 2nd. The seminar was evaluated by the participants and NFYOG board and viewed a success. A short board meeting was held immediately after the seminar. In the fall of 2007 a board meeting was held in Stockholm. Susanne Hesselman resigned as President when she went on maternity leave. Stig Hill was elected new President of NFYOG. Both the Swedish board members (Åsa and Susanne) resigned. Planning of the precongress seminar in Reykjavik and commencement of planning of the NFYOG seminar in 2009 was begun.

Current NFYOG board NFYOG President Stig Hill, Norway

Treasurer Dögg Hauksdóttir, Iceland

Members Paivi K Rahkola, Finland Jatta Rautkorpi, Finland Jens Fuglsang, Denmark NN, Denmark Vilde Lehland, Norway Malin Strand, Sweden NN, Sweden Ágúst Ingi Ágústsson, Iceland

Regards Stig Hill President of NFYOG

NFOG National Societies

Country Society Chairmen Active members (n) Abstracts at NFOG Congress 2008 (n)

Denmark DSOG Morten Lebech 763 in DK, 33 abroad 62 Finland SGY Juha Tapanainen 845 34 Iceland FIFK Arnar Hauksson 37 19 Norway NGF Rolf Kirschner 715 38 Sweden SFOG Charlotta Grunewald 1747 57 Total 4140 210

In addition to the Chairmen of the National Societies, the NFOG board consist of the following members President: Seija Grénman, Finland Secretary General: Ragnheidur I. Bjarnadóttir, Iceland Treasurer: Martin Stjernquist, Sweden Congress President of NFOG 2008: Thóra Steingrímsdóttir, Iceland Chairman of Scientific Committee: Lars-Åke Mattsson, Sweden Chairman of Educational Committee: Anders Atke, Denmark Chairman of NFYOG: Stig Hill, Norway Chief Editor of Acta: Reynir T. Geirsson, Iceland Webmaster (www.nfog.org): Peter Secher, Denmark

NFOG 2008 5 PROGRAMME OVERVIEW

Saturday June 14th

09:00 Precourse: Clinical Andrology. Physical examination and use of laboratory tests (CME points 8) 15:00 NFYOG Symposium: Nordic Federation of Young Obstetricians and Gynecologists. Obstetrics, a threatened speciality. Britt-Ingjerd Nesheim NO 16:00–18:00 Congress Registration 18:00 Welcome – Get together

Sunday June 15th

Main Hall Hall 1

08:00 Congress Registration 09:00 Opening ceremony Thóra Steingrímsdóttir; Seija Grénman; Alexander Smárason; Reynir Tómas Geirsson Young Scientist Award; Best Acta Article Award; Lillehammer Stipendium; Artists: Fífilbrekkuhópurinn 09:30 Opening lecture Addressing barriers to access to sexual and reproductive health care Dorothy Shaw, FIGO president, CAN 10:30 Coffee Break / Exhibition 11:00 NFOG Symposium: Women’s health in a global perspective Introduction; Women´s Health in a Global Perspective; Peter Hornnes DK Maternal mortality with emphasis on post partum hemorrhage; Roland Strand SE HIV/AIDS and sexual and reproductive health and rights – what are the links? Jerker Liljestrand SE How can ob-gyn societies be useful partners in twinning? Charlotta Grunewald SE 12:30 Lunch Break 13:30 Plenary lecture Congential Anomalies of the Reproductive Tract; Marc Laufer US 14:15 Human Papilloma Virus Skills training, simulation and assessment I Efficacy of vaccines. Who should get them? Nubia Munoz FR Implementation and evaluation of multiprofessional skills Short and long term consequences of vaccination; training in obstetrics; Jette Led Sørensen DK Jorma Paavonen FI The SaFE Study: a randomised controlled trial of obstetric Should HPV testing be the primary test in screening programmes? simulation training; Johanna Crofts UK Philip Davies FR Research into Obstetric Training – ‘What are the Active Other indications for HPV testing; Joakim Dillner SE Ingredients of Effective Training ?’ Tim Draycott UK Hands on test of obstetric and gynecological simulators and assessment bench stations available all days 15:45 Coffee Break / Exhibition 16:15 Ovarian cancer Hormones and wellbeing: Testosterone, Cytoreduction for Ovarian Cancer – Are Advanced Techniques Progesterone, Estrogens of Any Use for the Patients? William Cliby US Estrogen and Cognition; Päivi Polo FI Ovarian cancer – Centralization of surgical treatment; Progesterone and progestagens influence on memory Björn Hagen NO and learning; Torbjörn Bäckström SE Prognostic markers, has anything happened during the last Testosterone treatment in women; 25 years? Claes Högdall DK Angelique Flöter Rådestad SE New treatment modalities; Mark Baekelandt NO 17:30–18:30 Poster session: Authors are present by their posters and ready for discussion. Refreshments

6 NFOG 2008 Hall 2 Hall 3

Women’s health. Free communications I Ultrasound for fun Introduction; Ove Axelsson SE Epidemiological studies on safety; Helle Kieler SE Animal studies on ultrasound bioeffects; Kjell Å Salvesen NO Safety recommendations; Ove Axelsson SE Possible advantages of 3 and 4 D ultrasound in obstetrics; Elisabeth Epstein SE

Prenatal diagnosis. Free communications II Obesity Morbid obesity-a silent killer? Jøran Sture Hjelmesæth NO Obesity and reproduction; Tom Tanbo NO Overweight and pregnancy; Tore Henriksen NO

NFOG 2008 7 Monday June 16th

Main Hall Hall 1

08:15 Plenary lecture: Preeclampsia James Walker UK 09:00 Skills training, simulation and assessment II Rare serious events in obstetrics Organisation of training and intergration of skill training in the Eclampsia and Acute Fatty Liver of Pregnancy: The study of rare curriculum on a local, regional and nation level; disorders of pregnancy using the UK Obstetric Surveillance Guyliane Lefebvre, CA System (UKOSS); Marian Knight UK Simulator training and assessment in laparoscopic gynecology; European Obstetric Survey System, EUROSS – The Nordic Christian Rifbjerg Larsen DK perspective; Jens Langhoff-Roos DK The surgical curriculum; an evidence-based approach; Experiences from a center for pregnant women with Teodor Grantcharov CA heart disease; Marianne Johannesen DK Hysterectomy for life-threatening peripartum haemorrhage: Study of a ‘near-miss’ event; Marian Knight UK 10:30 Coffee Break / Exhibition 11:00 Hormone treatment in the climacteric – options for Severe maternal hemorrhage today and tomorrow Pathophysiology of severe PPH and general management; Is there a “window of opportunity”? Göran Samsioe SE Jouni Ahonen FI Alternative treatment from an evidence based perspective; Placenta acreta; Adam Borgida, US Mette Moen NO New methods in treating severe postpartum hemorrhage; Guidelines for HT from an international perspective; Kjell Å. Salvesen NO Sven Skouby DK

12:30 Lunch symposium – sponsored by Sanofi Pasteur MSD Latest Clinical Update on Gardasil Opening Introduction; Cecilia Young GARDASIL® (Quadrivalent HPV Recombinant Vaccine): An update with four years clinical efficacy data; Nubia Munoz Benefits of GardasilR – on other HPV types – in women above 25 years; Ole-Erik Iversen 12:30 General Assembly – Hall 4 14:00 Plenary: Should we discontinue public funding of assisted reproduction? Why are European laws on reproduction so similar?Paul Devroey BE It is a mistake to limit public funding for assisted reproduction; Hans Evers NL 14:45 Genetic medicine Fear of childbirth – what is it about and what can we do? Genetic counselling: psychosocial issues and decision making; Depression and anxiety during pregnancy – prevalence and Heather Skirton UK obstetric outcome; Liselott Andersson SE Heritable gynecological cancer; Anne-Marie Gerdes DK Violence against women may influence childbirth; Berit Schei NO Combined risk assessment for fetal aneuploidy with nuchal Fear of childbirth and the wish for a cesarean; translucency and biochemical markers. The Danish experience, Elsa Lena Ryding, SE before and after the guidelines from Sundhedsstyrelsen; Fear of childbirth can be treated and cesarean section avoided; Ann Tabor DK Terhi Saisto FI

16:15 Coffee Break / Exhibition 16:45 Genetic medicine (cont´d) Preterm birth Prenatal screening for fetal aneuploidy in the first trimester. Patophysiology of preterm birth; Nuchal translucency and biochemical markers; Adam Borgida US Henrik Hagberg SE Prenatal screening for structural malformations in the first trimester; Clinical management of preterm birth; Hulda Hjartardóttir IS Jan Stener Jörgensen DK

20:00 Gala dinner

8 NFOG 2008 Hall 2 Hall 3

Oncology. Free communications III Medical Cervical ripening; Helena von Hertzen WHO Contraception after abortion; Oskari Heikinheimo FI in late first trimester (9–12w); Ole-Erik Iversen NO Medical abortion in very early pregnancy; Christian Fiala AT Home-use of in medical abortion; Kristina Gemzell Danielsson SE

Fetal surveillance. Free communications IV Contraception The changing panorama of contraceptive use in the Nordic countries; Ian Milsom SE The use of LNG-IUS in nulliparous women; Satu Suhonen FI Menstrual cycle suppression. An endocrine treatment and a modern solution to a modern problem; Leslie Miller UK Hormonal contraception and risk of venous thromboembolism. Dose reduction matters; Øjvind Lidegaard DK Lunch symposium – sponsored by Renapharma Postpartum anemia – what is the optimal treatment? Erythropoiesis during pregnancy; Ivor Cavill UK IV iron vs oral iron. Results of the Norwegian Multicenter Study; Stian Westad NO IV ferric carboxymaltose. Results of the American Multicenter Study; Tom Goodnough USA Blood transfusion? No, thank you!; Ivor Cavill UK

Symposium – sponsored by Bayer Schering Pharma Presentation of theses New research: Important data for counseling your Diet and lifestyle of women of childbearing age – Impact of cod liver oil OC patients consumption on maternal health, birth outcome and breast milk Bayer Schering Pharma: Taking a leading role in woman´s health composition and associations between diet, lifestyle and weight gain in research; Maureen Cronin (Bayer Schering Pharma) pregnancy; Anna Sigríður Ólafsdóttir IS EURAS: The largest European active surveillance study on the safety Primary fallopian tube carcinoma: occurence, risk and prognostic factors; and efficacy of OC use; Juergen Dinger DE Annika Riska FI Health Authority representative; Steinar Madsen Biochemical and Epidemiological Studies of Early-Onset and Late-Onset New major studies on the protective effect of OC use on ovarian Preeclampsia; Anna Karin Wikström SE and endometrial cancer; Ian Milsom SE Total versus subtotal hysterectomy for benign uterine diseases?; Putting the new data into perspective for your OC patient; Helga Gimbel DK Maureen Cronin Portal and umbilical venous distribution in the human ; Jörg Kessler NO

Obstetrics – focus on the mother. Free communications V New trends in handling male infertility New trends in handling male infertility – Male infertility tests in the era of ICSI. Are genetic tests coming ? Ulrik Kvist SE Are sperm tests vanishing? Aleksander Giwercman SE Cryopreservation of testicular tissue; Claus Yding Andersen DK and Erik Ernst DK

NFOG 2008 9 Tuesday June 17th Iceland´s Independence Day

Main Hall Hall 1

09:00 Plenary: Anatomy of the pelvic floor Steven Swift USA 09:45 Pregnancy, delivery and the pelvic floor Pediatric and adolescent gynecology Epidemiology of female urinary incontinence and prolapse – Gynecological examination of children and adolescents; the impact of pregnancy and delivery; Guri Rørtveit NO Minna Joki-Erkkilä FI Teaching doctors to diagnose and repair perineal lesions; Chlamydia infection – a worry for the young women or for the Ranee Thakar UK gynecologist? Finn Egil Skjeldestad NO Teaching midwifes to diagnose and repair perineal lesions; Trends in adolescent abortion and pregnancy rates in the Sara Kindberg DK Nordic countries; Dan Apter FI Obstetrical lesions and the importance of the quality of A model for providing contraception and other services for primary repair; Abdul Sultan UK adolescents; Lena Marions SE Panel Debate 11:00 Coffe Break / Exhibition 11:30 New technologies in pelvic surgery – what is the evidence? Polycystic ovarian syndrome What is the best sling for stress urinary incontinence? Introduction; Jens A Gudmundsson IS Antti Valpas FI In utero veritas. Fetal intrauterine androgen exposure and PCOS; The use of implants in surgery for pelvic organ prolapse – evidence Sven Magnus Carlsen NO or marketing? Daniel Altman SE The fertility aspects of PCOS; Laure Morin-Papunen FI Emerging complications with novel technologies in pelvic surgery; When pregnant – then what? Eszter Vanky NO Eckhard Petri DE Scientific, ethical and legal implications of introducing new technologies in pelvic surgery; Gunnar Lose DK

13:00 Closing ceremony Prizes awarded for best presentations Refreshments

10 NFOG 2008 Hall 2 Hall 3

Premenstrual syndrome/Premenstrual dysphoric disorder Obstetrics – focus on the fetus. Free communications VI Etiology and pathogenesis of PMDD/PMS; Torbjörn Bäckström SE Treatment of premenstrual dysphoric disorder; Inger Sundström Poromaa SE

Postterm pregnancies Gynecology. Free communications VII Induction of post term pregnancy – time to reconsider? Jacob Nakling NO Routine induction of labour at 41 weeks gestation: Nonsensus Consensus; Kåre Augensen NO Management of post-date pregnancy: Todays’ evidence; Ulla Britt Wennerholm SE Induction of labour or serial antenatal fetal monitoring in post-term pregnancy? A randomised controlled trial; Runa Heimstad

NFOG 2008 11 SOCIAL PROGRAMME

Saturday June 14th 18:00–20:00 Welcome and get together party Welcome and get-together party with entertainment and light refreshments is at Listasafn Reykjavíkur – Reykjavík Art Museum, The Harbour House. The Harbour House, housed in the former Warehouses of the Port of Reykjavík, has diverse exhibitions of contemporary and experimental art, both Icelandic and international. The museum also houses the Erró Collection, a large collection of works by one of Iceland’s most celebrated modern artists – there are varying exhibitions on parts of this collection at the Museum. All participants and exhibitors are welcome. Please note that special transfer from hotels or congress venue is NOT provided

Sunday June 15th 18:30–23:00 Blue Lagoon tour with dinner The Blue Lagoon is a unique wonder of nature, a pool of natural mineral rich geothermal seawater in the middle of a lava field. The lagoon is rich in a unique natural combination of minerals. Blue-green algae and white Silica mud form natural sediment on the bottom of the lagoon and give the lagoon its soft, milky, aquamarine colour. The Blue Lagoon was created when hot water from the nearby “Svartsengi” geothermal power plant that formed due to heat exchange was discharged into the adjacent lava field. A visit to the Blue Lagoon is an invigorating and exciting experience. After relaxing bathe in the Blue Lagoon which is truly a unique experience a dinner will be served in the restaurant. Please note that swimming suits and towels are NOT provided. Departure from Háskólabíó – the Congress Venue Price per pers: ISK 9.100,- Tickets can be obtained at the Registration Desk

Monday June 16th 20:00–01:00 Gala dinner The Gala dinner is at Hilton Reykjavik Nordica which is located in Reykjavík, about 5 minutes drive from the Congress Venue. A 3 course delicious dinner with wine will be served. Icelandic artists will perform during dinner and the band “Hunang” will play for dance. Please note that special transfer from hotels is NOT provided to / from the Gala dinner. Price per pers: ISK 8.000,- Tickets can be obtained at the Registration Desk

Tuesday June 17th 14:00–19:00 The Golden Circle On this tour you will see the world-famous Geysir geothermal field and Gullfoss, the queen of Icelandic waterfalls. The Geysir geothermal field has spouting springs of various formations, bubbling hot water and exploding geysers while at Gullfoss you are given the opportunity to stand next to the amazing waterfall, watching its enormous quantities of water tumble violently into a deep, meandering gorge. Lunch and refreshments not included Includes: Bus fare and guidance in English. Departure from Háskólabíó – the Congress Venue Price per person: ISK 5.600,- Tickets can be obtained at the Registration Desk.

NFOG 2008 13 Tuesday June 17th 14:00–17:00 Þingvellir tour with Herb introduction Major events in the history of Iceland have taken place at Þingvellir, a declared National Park in 1930 and all Icelanders hold the place in high esteem. Today, Þingvellir is a protected national shrine. A law was passed designating Þingvellir as “a protected national shrine for all Icelanders, the perpetual property of the Icelandic nation under the preservation of a parliament, never to be sold or mortgaged.” The Þingvellir area is part of a fissure zone running through the country, being situated on the tectonic plate boundaries of the Mid-Atlantic Ridge. The faults and fissures of the area make evident the rifting of the earth’s crust. Today, Þingvellir is one of the most frequently visited tourist sites in the country. Each year, thousands of visitors go there to become better acquainted with Iceland’s greatest historical site and jewel of nature. On this tour you will also be introduced to Icelandic herbs. The group gathers around a table covered with Icelandic plants and herbs such as: Iceland moss, seaweed, angelica, and more. A guide explains the medicinal properties of those plants and gives examples of how the Icelanders use them to improve their health. The taste buds are teased with a refreshing herbal tea, some seaweed, warm milk infused with Iceland moss, and other traditional Icelandic herbal delicacies. The participants then get the secret recipe of the “sorcerer’s lupine root drink” plus a small goodbye present before heading back to Reykjavik Departure from Háskólabíó – the Congress Venue Price per person: ISK 7.100,- Tickets can be obtained at the Registration Desk.

Tuesday June 17th 14:00–18:00 Blue Lagoon tour The Blue Lagoon is a unique wonder of nature, a pool of natural mineral rich geothermal seawater in the middle of a lava field. The lagoon is rich in a unique natural combination of minerals. Blue-green algae and white Silica mud form natural sediment on the bottom of the lagoon and give the lagoon its soft, milky, aquamarine colour. The Blue Lagoon was created when hot water from the nearby “Svartsengi” geothermal power plant that formed due to heat exchange was discharged into the adjacent lava field. A visit to the Blue Lagoon is an invigorating and exciting experience Please note that swimming suits and towels are NOT provided. Departure from Háskólabíó – the Congress Venue Price per person: ISK 5.600,- Tickets can be obtained at the Registration Desk.

Tuesday June 17th 13:00 Closing Ceremony & Farewell drink by invitation of the organizing committee Sparkling wine, chocolate strawberries and marzipan sweeties are offered in the foyer after the Ceremony – as a NFOG 2008 Congress farewell drink and a celebration of the Icelandic Independence Day June 17th.

14 NFOG 2008 GENERAL INFORMATION

The Congress is held at Háskólabíó, The University Cinema Complex – www.haskolabio.is Háskólabíó is adjacent to the Radisson SAS Saga Hotel and close to the city centre of Reykjavík. All sessions will take place in the lecture halls of Háskólabíó and the exhibition is housed in the foyer. The address is: Háskólabíó, v/ Hagatorg, 107 Reykjavík – Iceland Tel: +354-525 5400, fax +354-525 5401 Contact person: Mr. Þorvaldur Kolbeins, [email protected], mobile: +354-893 9050

Banking Facilities A bank is located in the same building as Háskólabíó. Opening hours are Monday to Friday from 09:15–16:00. ATM is located outside the building.

Chairs Please be present in your session hall at least 10 minutes prior to your session. It is important that the session stay on schedule so that individuals who want to hear a specific talk may do so without concerns of time. It is thus vital that all speakers observe their time allotment.

Congress Badges Your personal badge is your entrance ticket to all sessions and you are asked to wear it throughout the congress. Should you misplace your badge a replacement can be obtained at the Congress hospitality desk. Organizing and Scientific committees have badges with yellow stripe and exhibitors with blue.

Credit Cards Commonly accepted cards in hotels, shops, restaurants and at the Congress hospitality desk: Visa, MasterCard, EuroCard, Diners and American Express.

Emergency Telephone number: 112

Excursions Excursions for participants and accompanying persons are available and detailed information and tickets can be obtained at the Congress hospitality desk.

Commercial Exhibition The exhibition is held in the foyer of the lecture halls and is open throughout the congress. List of the exhibitors and a map of the venue is in the programme. Exhibitors have badges with blue stripe.

Hospitality and Registration Desk The Congress Reykjavík is in charge of the registration, accommodation bookings, social arrangements, exhibition and excursions and general information. Tickets for social events and excursions can be obtained at the hospitality desk. The desk remains open during the congress. Telephone / mobile: Lára +354-896 6075, Tobba +354-862 4752, Imma +354-897 5559

Internet Café Internet Café with 6 computers will be located in the foyer of the Main Hall. Please observe the time limit of 10 minutes for each guest if there are other waiting. The Internet Café is sponsored by Bayer Schering Pharma.

Language All presentations are in English, no simultaneous interpretation is provided.

Lunches and coffee breaks Lunches and coffee, tea and refreshments are included in the registration fee and are served in the exhibition area.

NFOG 2008 15 Poster Display, set-up and removal Posters should be mounted by the presenters before 13:00, Sunday June 15 and dismantled on Tuesday June 17, before 12:00. Assistant will be present for any information or help on Sunday June 15, between 08:00–13.00. Posters are numbered in the programme and the boards accordingly. Please take notice of that before hanging up your poster. Posters left on poster boards will be removed by the organizer who can not be held liable for any loss or damage to posters beyond the official removal times. Posters are displayed in the foyer of the lecture halls.

Poster Session Time: Sunday June 15, 17:30–18:30 Author / authors are present by their poster and ready for discussion. Light refreshments (wine & cheese) will be served during the Poster session.

Professional Congress Organizer – PCO Congress Reykjavík, Conference Management Services Ltd. is the official organizing agency for the congress. The address is: Congress Reykjavik, Engjateigur 5, IS-105 Reykjavík, tel: +354-585 3900, fax: +354-585 3901 e-mail: [email protected], www.congress.is

Smoking Policy Smoking is not allowed inside the Congress Venue.

Speakers All speakers are asked to present themselves to the technician with their presentation at least one hour before the beginning of their session. Please note that you need to hand in your power point presentations on a CD-ROM or USB key. Assistance can be obtained in the speaker’s room.

Taxi Taxis are available outside all hotels and in the City Centre at a reasonable price. You can call a taxi on +354-561 0000

16 NFOG 2008 PROGRAMME

Saturday June 14th

09:00–17:00 Precourse: Clinical Andrology. Physical examination and use of laboratory tests (CME points 8) 15:00–17:00 NFYOG Symposium: Nordic Federation of Young Obstetricians and Gynecologists. Obstetrics, a threatened speciality. Britt-Ingjerd Nesheim, Norway 18:00–20:00 Welcome and Get-together party

Sunday June 15th

09:00–09:30 Opening Ceremony Main Hall

Thóra Steingrímsdóttir Seija Grénman Alexander Smárason Reynir Tómas Geirsson

Artists: Fífilbrekkuhópurinn Young Scientist Award Best Acta Article Award Lillehammer scolarship

09:30–10:30 Opening lecture Main Hall Chair: Reynir Tómas Geirsson IS-001 Addressing barriers to access to sexual and reproductive health care Dorothy Shaw FIGO president, University of British Columbia, VANCOUVER, Canada 10:30–11:00 Coffee Break / Exhibition

11:00–12:30 NFOG Symposium: Womens health in a global perspective Main Hall Chairs: Seija Grénman and Unni Kirste 11:00–11:20 IS-002 Women´s Health in a Global Perspective Peter Hornnes Hvidovre University Hospital, HVIDOVRE, Denmark 11:20–11:40 IS-003 Maternal mortality with emphasis on post partum haemorrhage (PPH) Roland Strand Kvinnokliniken, ESKILSTUNA, Sverige 11:40–12:00 IS-004 HIV/AIDS and sexual and reproductive health and rights – what are the links? Jerker Liljestrand Department of Health Sciences/Division of Social Medicine and Global Health, MALMÖ, Sweden 12:90–12:20 IS-005 How can ob-gyn societies be useful partners in twinning? Charlotta Grunewald SFOG, Dpt ObGyn South General Hospital, NACKA, Sweden 12:20–12:30 Discussion 12:30–13:30 Lunch Break

NFOG 2008 17 13:30–14:15 Plenary lecture Main Hall Chair: Mette Moen IS-006 Congential Anomalies of the Reproductive Tract Marc Laufer Children’s Hospital Boston, BOSTON, United States of America

14:15–15:45 Human Papilloma Virus Main Hall Chairs: Kristján Sigurðsson and Ole Erik Iversen 14:15–14:35 IS-007 Efficacy of HPV vaccines. Who should get them? Nubia Muñoz Emeritus professor at the National Cancer Institute of Colombia, Colombia / Lyon, France 14:35–14:55 IS-008 Short and long term consequences of HPV vaccination Jorma Paavonen Helsinki Unversity Central Hospital, HELSINKI, Finland 14:55–15:15 IS-009 Should HPV testing be the primary test in screening programmes? Philip Davies European Cervical Cancer Association, France 15:15–15:35 IS-010 Current and future indications of HPV testing Joakim Dillner Lund University, MALMÖ, Sweden 15:35–15:45 Discussion

14:15–15:45 Skills training, simulation and assessment I Hall 1 Chairs: Rolf Kirschner and Jan Stener Jørgensen 14:15–14:40 IS-011 Implementation and evaluation of multiprofessional skillstraining in obstetrics Jette Led Soerensen 1Rigshospitalet, COPENHAGEN, Denmark 14:40–15:05 IS-012 The SaFE Study: a randomised controlled trial of obstetric simulation training Joanna Crofts Southmead Hospital, BRISTOL, United Kingdom 15:05–15:30 IS-013 Research into Obstetric Training – ‘What are the Active Ingredients of Effective Training?’ Tim Draycott Southmead Hospital, BRISTOL, United Kingdom 15:30–15:45 Discussion Hands on test of obstetric and gynecological simulators and assessment bench stations available all days

14:15–15:45 Womens health. Free communications I Hall 2 Chairs: Satu Suhonen and Unni Kirste 14:15–14:25 WH1 Hormone Therapy and risk of Myocardial Infarction. Effect modification by concomittant medication for diabetes, hypertension, cholesterol and arrhythmia. A National register study Ellen Løkkegaard1, Anne Helms Andreasen2, Rikke Kart Jacobsen2, Lars Hougaard Nielsen2, Carsten Agger2, Øjvind Lidegaard3 1Glostrup Hospital, GLOSTRUP, Danmark 2Research Centre for Prevention and Health, The Capital Region of Denmark, GLOSTRUP, Danmark 3Gynaecological Clinic, Rigshospitalet, COPENHAGEN, Danmark

18 NFOG 2008 14:25–14:35 WH2 Prevalence of psychological, physical and sexual abuse in a national study in young men and women in Sweden Ingela Danielsson1, Helena Blom2, Carin Nilses3, Ulf Högberg4, Gun Heimer5 1Umeå University, UMEÅ, Sweden 2Department of Obstetrics and Gynecology, Sundsvall Hospital, SUNDSVLL, Sweden 3Department of Clinical Science, Obstetrics and Gynecology, UMEÅ, Sweden 4Department of Clincal Science Obstetrics and Gynecology, UMEÅ, Sweden 5National Centre for Knowledge on Men’s Violence against Women, UPPSALA, Sweden 14:35–14:45 WH3 Risk consumption of alcohol among students in secondary schools exposed to emotional, physical and sexual violence Carin Nilses1, Helena Blom2, Ingela Danielsson1 1Department of Clinical Science Obstetrics and Gynecology, UMEÅ, Sweden 2Department of Obsterics and Gynecology Sundsvall Hospital, SUNDSVALL, Sweden 14:45–14:55 WH4 Gynecologic fistula following sexual violence Mathias Onsrud1, Solbjørg Sjøveian1, Denis Mukwege2 1Ullevål University Hospital, OSLO, Norge 2Panzi University Hospital, BUKAVU, Congo 14:55–15:05 WH5 Injury documentation, forensic sampling and legal outcome in police reported sexual assaults of adult women Cecilie Therese Hagemann1, Lise Eileen Stene2, Kari Ormstad3, Berit Schei4 1St Olavs Hospital HF, TRONDHEIM, Norge 2Stavanger University Hospital, STAVANGER, Norge 3Institute of Forensic Medicine, University of Oslo, OSLO, Norge 4Faculty of Medicine, Norwegian University of Science and Technology, TRONDHEIM, Norge 15:05–15:15 WH6 Chlamydia trachomatis seroprevalence rates in Finland over two decades Jorma Paavonen1, E Lyytikäinen2, M Kaasila3, E Hiltunen-Back4, M Lehtinen5, K Tasanen6, H-M Surcel4, P Koskela4, J Paavonen1 1Helsinki University Central Hospital, HELSINKI, Finland 2National Public health Institute, OULU AND KUOPIO, Finland 3National Public Helath Institute, OULU AND KUOPIO, Finland 4National Public Health Institute, KUOPIO AND OULU, Finland 5University of Tampere, School of Public Health, TAMPERE, Finland 6Universiy of Oulu, Department of Dermatology, OULU, Finland 15:15–15:25 WH7 Sexuality, fertility and outcome of pregnancies in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Kerstin Hagenfeldt1, Per-Olof Janson2, Gundela Holmdahl3, Henrik Falhammar4, Helena Filipsson5, Louise Frisén6, Marja Thorén4, Agneta Nordenskjöld7 1Karolinska Institutet, STOCKHOLM, Sweden 2Dep Obstet/Gynecol, Sahlgrenska Hospital, GÖTEBORG, Sweden 3Pediatric Surgery, Queen Silvia Children´s Hospital, GÖTEBORG, Sweden 4Dep Endocrinology,Metabolism & Diabetes, Karolinska Institutet, STOCKHOLM, Sweden 5Dep of Endocrinology, Sahlgrenska University Hospital, GÖTEBORG, Sweden 6Dep of Clinical Sciences, Div of Psychiatry Danderyd´s Hospital, STOCKHOLM, Sweden 7Dep Molecular Med & Surgery and Pediatric Surgery, Karolinska Institutet, STOCKHOLM, Sweden

14:15–15:45 Ultrasound for fun Hall 3 Chairs: Bjørn Backe and Isis Amer Wåhlin 14:15–14:25 IS-014 Introduction Ove Axelsson Uppsala University, UPPSALA, Sweden 14:25–14:45 IS-015 Epidemiological studies on safety Helle Kieler Karolinska Institutet, STOCKHOLM, Sweden

NFOG 2008 19 14:45–15:00 IS-016 Animal studies on ultrasound bioeffects Kjell Salvesen National Center for Fetal Medicine, TRONDHEIM, Norway 15:00–15:10 IS-017 Safety recommendations Ove Axelsson Uppsala University, UPPSALA, Sweden 15:10–15:30 IS-018 Possible advantages of 3 and 4 D ultrasound in obstetrics Elisabeth Epstein Clinical sciences, Lund, LIMHAMN, Sweden 15:30–15:45 Discussion 15:45–16:15 Coffee Break / Exhibition

16:15–17:30 Ovarian cancer Main Hall Chairs: Bengt Tholander and Björn Hagen 16:15–16:45 IS-019 Cytoreduction for Ovarian Cancer – Are Advanced Techniques of Any Use for the Patients? William Cliby Mayo Clinic, ROCHESTER, MINNESOTA, USA 16:45–17:00 IS-020 Ovarian cancer – Centralization of surgical treatment Bjørn Hagen Trondheim Univ. Hosp., TRONDHEIM, Norway 17:00–17:15 IS-021 Prognostic markers, has anything happened during the last 25 years? Claus Høgdall Rigshospitalet, COPENHAGEN Ø, Denmark 17:15–17:30 IS-022 New treatment modalities Mark Baekelandt Norwegian Radium Hospital, Norway

16:15–17:30 Hormones and wellbeing: Testosterone, Progesterone, Estrogens Hall 1 Chairs: Kerstin Hagenfeldt and Risto Erkkola 16:15–16:35 IS-023 Estrogen and Cognition Päivi Polo-Kantola Turku University Hospital, TURKU, Finland 16:35–16:55 IS-024 Progesterone and progestagens influence on memory and learning Torbjörn Bäckström Umeå University Hospital, UMEÅ, Sweden 16:55–17:15 IS-025 Testosterone treatment in women Angelique Flöter Rådestad Karolinska University Hospital, STOCKHOLM, Sweden 17:15–17:30 Discussion

16:15–17:35 Prenetal diagnosis. Free communications II Hall 2 Chairs: Thue Bryndorf and Jörg Kessler 16:15–16:25 PD1 Invasive prenatal diagnosis in Denmark 2002–2006 Christina H. F. Vestergaard, Øjvind Lidegaard, Ann Tabor Rigshospitalet, KØBENHAVN Ø, Denmark 16:25–16:35 PD2 Knowledge and understanding of prenatal screening and testing before and after the introduction of information booklet Vigdís Stefánsdóttir1, Hildur Harðardóttir1, Jón Jóhannes Jónsson1, Heather Skirton2 1Landspitali University Hospital, REYKJAVÍK, Iceland 2University of Plymouth, TAUNTON, United Kingdom

20 NFOG 2008 16:35–16:45 PD3 Improved performance of first-trimester screening for trisomy 21 with the double test taken before a gestational age of 10 weeks Ida Kirkegaard1, Olav Bjorn Pedersen1, Niels Uldbjerg1, Niels Torring2 1Dept. Gynecology and Obstetrics, AARHUS C, Denmark 2Dept. Clinical Biochemistry, AARHUS, Denmark 16:45–16:55 PD4 First trimester screening in IVF/ICSI pregnancies: The significance of gestational dating by oocyte retrieval or crown rump length Anne Cathrine Gjerris1, A Loft2, A Piborg2, A Tabor3, M Christiansen4 1Rigshospitalet, Copenhagen University Hospital, COPENHAGEN, Denmark 2The Fertility Clinic, Rigshospitalet, University Hospital, COPENHAGEN, Denmark 3Department of Fetal Medicine, Rigshospitalet University Hospital, COPENHAGEN, Denmark 4Department of Clinical Biochemistry, Statens Serum Institut, COPENHAGEN, Denmark 16:55–17:05 PD5 ADAM12 is an efficient first trimester maternal serum marker for Michael Christiansen1, Kasper Pihl1, Paula Hedley1, Severin Larsen1, Lone Krebs2, Torben Larsen2 1Statens Serum Institut, COPENHAGEN, Denmark 2Holbæk Sygehus, HOLBÆK, Denmark 17:05–17:15 PD6 A new population based term prediction method – evaluation of the FL-based predictions Inger Økland1, Håkon K. Gjessing2, Per Grøttum3, Torbjørn M. Eggebø1, Sturla H. Eik-Nes4 1Stavanger University Hospital, STAVANGER, Norge 2Norwegian Institute of Public Health, OSLO, Norge 3University of Oslo, OSLO, Norge 4National Center for Fetal Medicine, Norwegian University of Science and Technolo, TRONDHEIM, Norge 17:15–17:25 PD7 Neonatal alloimmune thrombocytopenia (NAIT) in Norway: Under diagnosed with non- screening versus a general screening program. Maternal anti-HLA class 1 antibodies as cause of neonatal alloimmune thrombocytopenia (NAIT) – no longer a myth? Heidi Tiller, Mette Kjær Killie, Bjørn Skogen, Pål Øian, Anne Husebekk University Hospital of North Norway, TROMSO, Norway 17:25–17:35 PD8 Prenatal ultrasound and childhood brain tumours Karin Stalberg1, Bengt Haglund2, Ove Axelsson3, Sven Cnattingius4, Susan Pfeifer5, Helle Kieler6 1Uppsala Universitet, UPPSALA, Sverige 2Centre for Epidemiology, National Board of Health and Welfare, STOCKHOLM, Sverige 3Department of Women’s and Children’s Health, Obstetrics and Gynecology, UPPSALA, Sverige 4Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, STOCKHOLM, Sverige 5Department of Genetics and Pathology, Rudbeck Laboratory, UPPSALA, Sverige 6Centre for Pharmacoepidemiology, Karolinska Institutet, STOCKHOLM, Sverige

16:15–17:30 Obesity Hall 3 Chairs: Helena Strevens and Elisabeth Darj 16:15–16:35 IS-026 Morbid obesity – silent killer? Jøran Hjelmesæth Morbid Obesity Centre, TØNSBERG, Norway 16:35–16:55 IS-027 Obesity and reproduction Tom Tanbo Rikshospitalet University Hospital, OSLO, Norway 16:55–17:20 IS-028 OVERWEIGHT AND PREGNANCY Tore Henriksen University of Oslo, OSLO, Norway 17:20–17:30 Discussion

NFOG 2008 21 17:30–18:30 Poster session – Authors are present by their posters and ready for discussion Refreshments Acta Prize Winner P001 Placental abruption: risk factors and biochemical markers Tikkanen M, Paavonen J, Nuutila M, Hiilesmaa V, Ylikorkala O Department of Obstetrics and Gynecology, University of Helsinki, Finland P002 Iceland – Prenatal screening in the first trimester Hildur Harðardóttir, María Hreinsdóttir, Hulda Hjartardóttir, Jón Jóhannes Jónsson Landspitali University Hospital, REYKJAVÍK, Iceland P003 Declining number of invasive procedures for prenatal aneuploidy diagnosis Hildur Harðardóttir, Hulda Hjartardóttir, Kristín Rut Haraldsdóttir, María Hreinsdóttir Landspitali University Hospital, REYKJAVIK, Iceland P004 Maternal serum leptin is not a first trimester marker of foetal Down syndrome Paula Hedley, Michael Christiansen Statens Serum Institut, COPENHAGEN, Denmark P005 Need for chromosomal diagnosis in single umbilical artery Lone Laursen, Ole Mogensen University Hospital of Odense, ODENSE, Denmark P006 Title Ascertainment Deficiencies of the Swedish Birth Defects Registry and the Incidence of Cleft Lip/Palate and Spina Bifida in Sweden Hashem Amini1, Ove Axelsson1, Birgitta Ollars2, Göran Annerén3 1Department of Women and Children´s Health Uppsala University, UPPSALA, Sweden 2Swedish Registry of Birth Defects, National Board of Health and Welfare, STOCKHOLM, Sweden 3Dep of Genetics and Pathology, Uppsala University, UPPSALA, Sweden P007 Obese women have an increased risk for erroneous ultrasound dating in second trimester Marija Simic1, Isis Amer-Wahlin2, Karel Marsal3, Karin Källén4 1Karolinska University hospital, STOCKHOLM, Sverige 2Karolinska institutet, STOCKHOLM, Sverige 3Dept of Ob and Gyn, University Hospital Lund, LUND, Sverige 4Tornblad institute,University of Lund, LUND, Sweden P008 Intervention program for obese pregnant woman Elisabeth Storck Lindholm, Margareta Norman, Daniel Altman Danderyds sjukhus, STOCKHOLM, Sweden P009 Delivery complications: The role of lifestyle related factors Nanna Voldner1, Kathrine Froslie1, Kari Bo2, Lene Haakstad2, Jens Bollerslev1, Tore Henriksen1 1Rikshospitalet Medical Centre, OSLO, Norway 2Norwegian School of Sport Science, OSLO, Norway P010 Maternal metabolic syndrome and macrosomia in healthy Norwegian gravida Nanna Voldner, Elisabeth Qvigstad, Kathrine Froslie, Tore Henriksen, Jens Bollerslev Rikshospitalet Medical Centre, OSLO, Norway P011 A longitudinal study of six humoral inflammatory markers in pregnancy. Relation to obesity Camilla Hoff, Katrine Frey Frøslie, Nanna Voldner, Kristin Godang, Jens Bollerslev, Tore Henriksen Rikshospitalet, OSLO, Norge P012 Pregnancy outcome in overweight and obese women Ólöf Elíasdóttir, Hildur Harðardóttir, Þórður Þórkelsson University of Iceland, REYKJAVÍK, Iceland

22 NFOG 2008 P013 The Effect of Pre-pregnancy Body Mass Index (BMI) and Weight Gain in Pregnancy on Cesarean Section Rate in Spontaneous Labour Alexander Smárason1, Tatjana Aberle2, Ingibjörg Jónsdóttir2 1Intitution of Health Science Research, University of Akureyri, AKUREYRI, Iceland 2FSA, University Hospital, AKUREYRI, Iceland P014 The relation between birth weight and hypertension among Danish nurses with and without a familial pre-disposition to obesity Rie Adser Virkus1, Berit Heitmann2, Ellen Christine Løkkegaard3, Thomas Bergholdt1, Morten Hedegaard4, Bent Ottesen5 1Hillerød Hospital, HILLERØD, Denmark 2Research Unit for Dietary Studies and the Danish Epidemiology Science Center at, COPENHAGEN, Danmark 3Glostrup sygehus, GLOSTRUP, Danmark 4Juliane Marie Center, Rigshospitalet, COPENHAGEN, Denmark 5Juliane Mariecenteret, Rigshospitalet, COPENHAGEN, Danmark P015 Does coffee intake during pregnancy prevent gestational diabetes mellitus? Birgitte Bruun Nielsen, Per Ovesen, Tine Brink Henriksen Aarhus University Hospital, Skejby, AARHUS, Denmark P016 Management of insulin dependent diabetes mellitus in pregnancy during a 26 year period at Danderyd Hospital Margareta Nyman1, Elisabeth Lindholm2, Per-Eric Lins2, Margareta Norman3 1Danderyd Hospital, STOCKHOLM, Sweden 2Sweden 3Danderyds sjukhus, STOCKHOLM, Sweden P017 Blood glucose home monitoring -based therapy in gestational diabetes leads to reduced number of macrosomic infants Jukka Uotila, Sirkku Tulokas Tampere University Hospital, TAMPERE, Finland P018 Changes of endothelial function in preeclampsia during pregnancy, early and late postpartum Rangeen Rafik Hamad1, Maria J Eriksson2, Katarina Bremme1 1Karolinska Institutet, STOCKHOLM, Sweden 2Department of Clinical Physiology, KAROLINSKA HOSPITAL/STOCKHOLM, Sweden P019 Ang-1/Ang-2 ratio as a predictive biomarker for preeclampsia Helena Åkerud1, Anders Larsson2, Matts Olovsson3 1Dept of Women´s and Children's Health, Uppsala University, UPPSALA, Sweden 2Dept of Medical Sciences, Clinical Chemistry, UPPSALA, Sweden 3Dept of Women´s and Childrens Health, Uppsala University, UPPSALA, Sweden P020 Maternal serum leptin is a first trimester marker of pre-eclampsia Paula Hedley, Michael Christiansen Statens Serum Institut, COPENHAGEN, Denmark P021 Case report of severe thrombocytopenia in pregnancy Kadi Ploom East Tallinn Central Hospital, TALLINN, Estonia P022 Q-fever during pregnancy: a case report Lise Lotte Torvin Andersen, Kirsten Marie Schiøtt Odense University Hospital, ODENSE M, Danmark P023 Acute Q-fever in pregnancy – A matter of concern to Obstetricians in the Nordic Countries? Kirsten Marie Schiøtt, Lise Lotte Torvin Andersen Odense University Hospital, ODENSE, Denmark

NFOG 2008 23 P024 Uterine artery pseudoaneurysm resulting from hidden uterine rupture missinterpreted as a lower uterine segment necrotic myoma Ajlana Mulic-Lutvica Institute of Women's and Children's Health, UPPSALA, Sverige P025 Pre-pregnancy transabdominal cerclage in women with previous second trimester deliveries Lea Langhoff Thuesen, Birgitte Rode Diness, Jens Langhoff-Roos Rigshospitalet, COPENHAGEN, Denmark P026 The growth hormone axis in twin pregnancies Jens Fuglsang1, Sanne Fisker2, Niels Møller2, Per Ovesen3 1Aarhus Universitetshospital, Skejby, & Regionshospitalet Herning, AARHUS N, Danmark 2Medical Research Laboratories, Aarhus University Hospital, AARHUS C, Danmark 3Gynaecological/Obstetrical Dept. Y, Aarhus University Hospital., AARHUS N, Danmark P027 Nitric oxide induced morphological changes in the human uterine cervix studied by electron microscopy Maria Bullarbo, Erling Ekerhovd, Nina Radulovic, Anders Norström Institution of clinical sciences, GÖTEBORG, Sweden P028 Vaginal nitro induces cervical nitric oxide release in women postterm Mervi Väisänen-Tommiska, Tomi Mikkola, Olavi Ylikorkala Helsinki University Central Hospital, HELSINKI, Finland P029 Cervical biopsies can be send by mail for assessment of cervical incompetence Iben Sundtoft1, Niels Uldbjer2, Ole Bjarne Christiansen3, Steffen Sommer4 1Aarhus University Hospital Skejby, AARHUS N, Denmark 2Department of Obstetrics and Gynecology, Aarhus University Hospital Skejby, DK-8200 AARHUS N, Denmark 3The Fertility Clinic, University Hospital Copenhagen, Rigshospitalet, COPENHAGEN, Denmark 4Department of Obstetrics and Gynecology, Horsens Regional, DK-8700 HORSENS, Denmark P030 Comparison of Three Modes of Administration of Prostaglandin for Induction of Labour Morten Beck Sorensen1, Clair Evans2, Ada Ekpe2, Christina Cotzias2 1West Middlesex University Hospital, LONDON, United Kingdom 2West Middlesex Hospital, LONDON, United Kingdom P031 Association between lactate concentration in amniotic fluid (AF) and labour dystocia Eva Wiberg-Itzel, Lennart Nordstrom Karolinska Institute, DANDERYD, Sverige P032 Decreased Cesarean Section Rate after the Introduction of Robson´s 10 Group Classification System Jón Gylfason1, Ásta Eymundsdóttir1, Ingibjörg Jónsdóttir1, Alexander Smárason2 1FSA University Hospital, AKUREYRI, Iceland 2Institution of Health Science Reasearch, University of Akureyri, AKUREYRI, Iceland P033 Vaginal birth following one prior cesarean section Brynhildur Tinna Birgisdóttir, Hildur Harðardóttir, Ragnheiður Bjarnadóttir, Þórður Þórkelsson Landspitali University Hospital, REYKJAVÍK, Iceland P034 Continuous uterine massage in cases with retained placenta reduces blood loss? Maria Jonsson1, Ulf Hanson1, Annie Sigfusdottir2 1Department of Women’s and Children’s Health Uppsala University Uppsala, UPPSALA, Sweden 2Department of Obstetrics and Gynecology, Uppsala University Hospital, UPPSALA, Sverige P035 Fire drills in obstetric emergencies Pernille Lottrup, Mette Simonsen, Hanne Kjaergaard, Marianne Johansen, Bent Ottesen, Jette Led Soerensen The Juliane Marie Centre for Children, Women and Reproduction Copenhagen Univers, COPENHAGEN Ø, Danmark

24 NFOG 2008 P036 Breech delivery Jatta Tuohimaa, Tuija Heikkinen Turku University Hospital, TURKU, Finland P037 Post-partum urinary tract infection Rita Andersen Leth1, Jens Kjølseth Møller1, Reimar W. Thomsen2, Niels Uldbjerg1, Mette Nørgaard2 1Aarhus University Hospital, Skejby, AARHUS N, Denmark 2Aarhus University Hospital, Aalborg Sygehus, AARHUS, Denmark P038 Cesarean Section and Maternal Complications Nanneli Pallasmaa1, Ulla Ekblad1, Ansa Aitokallio-Tallberg2, Jukka Uotila3, Tytti Raudaskoski4, Veli-Matti Ulander2 1Turku University Central Hospital, TURKU, Finland 2Helsinki University Central Hospital, HELSINKI, Finland 3Tampere University Hospital, TAMPERE, Finland 4Oulu University Hospital, OULU, Finland P039 Complications of caesarean section Heiðdís Valgeirsdóttir, Hildur Harðardóttir, Ragnheiður Bjarnadóttir Landspitali University Hospital, REYKJAVÍK, Iceland P040 Mode of delivery in UK mothers with HIV Britt Clausson, Stella Sebuwufu Mayday University Hospital, CROYDON, United Kingdom P041 Does TachoSil® improve the healing of the myometrium after cesarean section? Gitte Bennich, Lene B Paulsen, Pernille Nørgaard, Martin Rudnicki Roskilde University Hospital, ROSKILDE, Danmark P042 Caesarean section and risk for pelvic organ prolapse – an epidemiologic register study and a metaanalysis Christina Larsson Karolinska Institute, STOCKHOLM, Sverige P043 Effect of cimetidine on the transfer of metformin in dually perfused human placenta Kristiina Tertti1, Ulla Ekblad1, Tuija Heikkinen1, Melissa Rahi1, Tapani Rönnemaa1, Kari Laine2 1Turku University Central Hospital, TURKU, Finland 2University of Turku, TURKU, Finland P044 Placental infarcts in preeclamptic, gestational hypertensive, Intrauterine Growth Retardation (IUGR) and normotensive pregnancies Anita Sylvest Andersen1, Ulla Engel2, Anne Wåhlin2, Helle Christina Sørensen3, Jørgen G Berthelsen4, Michael Rud Lassen5, Thomas Bergholt4 1Hillerød Hospital, HILLERØD, Denmark 2Department of Pathology, Hospital Hospital, HILLERØD, Denmark 3Department of Gynecology and Obstetrics, Glostrup Hospital, GLOSTRUP, Denmark 4Department of Gynecology and Obstetrics, Hillerød Hospital, HILLERØD, Denmark 5Clinical Trial Unit, Hørsholm Hospital, HØRSHOLM, Denmark P045 Histopathological examination of PCOS placentas – metformin or placebo in pregnancy Solhild Stridsklev, Eszter Vanky, Sven Carlsen, Christina Vogt Isaksen NTNU/ St. Olavs Hospital, TRONDHEIM, Norway P046 Maternal risk factors for fetal growth restriction (FGR) in Latvia Natalija Vedmedovska1, Dace Ezerina2, Dace Rezeberga1, Irina Jermakova2 1Riga Stradins University, RIGA, Latvia 2Riga Maternity Hospital, RIGA, Latvia P047 Respiratory dysfunction in infants born by elective cesarean section without labor Snorri Dónaldsson, Hildur Hardardottir, Þórður Þórkelsson, Atli Dagbjartsson, Hörður Bergsteinsson, Ásgeir Haraldsson Landspitali University Hospital, REYKJAVÍK, Iceland

NFOG 2008 25 P048 Oxygen transport to the fetus during normal vaginal delivery and during elective Cesarean section Thordur Thorkelsson1, Anton Bjarnason1, Hildur Hardardottir2, Adalbjorn Thorsteinsson2, Asgeir Haraldsson1, Atli Dagbjartsson1 1Children's Hospital Iceland, REYKJAVIK, Iceland 2National University Hospital Iceland, Dpt. of obstetrics and gynecoogy, REYKJAVIK, Iceland P049 Birth asphyxia and hypoxic ischemic encephalopathy, incidence and obstetric risk factors Kolbrún Pálsdóttir, Hildur Hardardottir, Þórður Þórkelsson, Atli Dagbjartsson Landspitali University Hospital, REYKJAVÍK, Iceland P050 Birth asphyxia, neonatal risk factors for hypoxic ischemic encephalopathy Kolbrún Pálsdóttir, Hildur Hardardottir, Þórður Þórkelsson, Atli Dagbjartsson Landspitali University Hospital, REYKJAVÍK, Iceland P051 Assessment of perinatal outcome – analysis of 7 years of STAN usage in normal pregnancies Håkan Norén, Ann Carlsson Sahlgrenska university hospital, MÖLNDAL, Sweden P052 Low umbilical artery pH level at birth associates with the development of asthma among 5–6 year old children Leea Keski-Nisula1, Baizhuang Xu2, Tuula Putus2, Juha Pekkanen2 1Kuopio University Hospital, KUOPIO, Finland 2Unit of Environmental Epidemiology, National Public Health Institute, KUOPIO, Finland P053 Risks associated with extremely large babies Harpa Vidarsdottir2, Reynir Tómas Geirsson1, Atli Dagbjartsson3, Hildur Hardardottir1, Unnur Valdimarsdottir2 1Landspitali University Hospital, REYKJAVIK, Iceland 2University of Iceland, REYKJAVIK, Iceland 3Landspitali University Hospital, Dept. of Pediatrics, REYKJAVIK, Iceland P054 Pregnancy exposure to venlafaxine, preterm delivery and Apgar score Lars Henning Pedersen1, Tine Brink Henriksen2, Jørn Olsen3 1University of Aarhus, Dept. of Epidemiology, AARHUS C, Danmark 2Perinatal Epidemiology Research Unit, Dept. of Pediatrics, Aarhus University, AARHUS, Danmark 3UCLA School of Public Health, Dept. of Epidemiology, LOS ANGELES, CALIFORNIA, USA P055 PCOS and breast feeding Eszter Vanky Inst of laboratory medicine, childrens and womens health, TRONDHEIM, Norge P056 Maternal androgen levels associate negatively with breastfeeding Sven Magnus Carlsen1, Geir Jacobsen2, Eszter Vanky1 1Inst. for laboratory medicine, childrens and womens health, TRONDHEIM, Norge 2Department of Public Health and General Practice, TRONDHEIM, Norge P057 Maternal mortality and near-miss morbidity in metropolitan La Paz, Bolivia Mattias Rööst1, Jerker Liljestrand2, Birgitta Essén1 1International Maternal and Child Health, IMCH, Uppsala University, UPPSALA, Sweden 2Department of Health Sciences/Division of Social Medicine and Global Health, MALMÖ, Sverige P058 Physical and mental handicaps among women examined at center for victims of sexual assault (CFVSA) in copenhagen Malene Hilden, Katrine Sidenius Rigshospitalet, COPENHAGEN, Denmark P059 TNF-a polymorphism and pathogenesis of Chlamydia trachomatis associated infertility Jorma Paavonen1, H Öhman2, A Tiitinen1, M Halttunen1, M Lehtinen3, J Paavonen1, H-M Surcel2 1Helsinki University Central Hospital, HELSINKI, Finland 2National Public Health Institute, OULU, Finland 3University of Tampere, School of Public Health, TAMPERE, Finland

26 NFOG 2008 P060 Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo- controlled study Per-Göran Larsson1, Babill Stray-Pedersen2, Keld Ryttig3, Stig Larsen4, Preben Borelli5 1Kvinnokliniken, SKÖVDE, Sweden 2Rikshospitalet, OSLO, Norge 3Farmaservice, KÖPENHAMN, Danmark 4Scolle of veterinary Science, Ullevål, OSLO, Norge 5Bifodan A/S, HUNDESTAD, Denmark P061 The Effect of Endometrial Thickness on Invitrofertilization (IVF)-Embryo Transfer/Intracytoplasmic Sperm Injection (ICSI) Outcome Jude Okohue1, Sunday Onuh2, Sunday Shaibu2, Peter Ebeigbe3, Ibrahim Wada2, Eugene Okpere4 1Prime medical consultants, PORTHARCOURT,RIVERS STATE, Nigeria 2Nordica fertility centre@ Nisa premier hospital, ABUJA, Nigeria 3Department of obstet/gynaecol, college of medicine, Delta state university, DELTA, Nigeria 4Department of obstet/gynaecol, University of Benin Teaching Hospital, EDO, Nigeria P062 Intrauterine polyps and their influence om infertility Ditte Josefine Roerne1, Helle Vibeke Clausen1, Søren Stampe Sørensen2 1Herlev University hospital, HERLEV, Denmark 2Glostrup University Hospital, GLOSTRUP, Denmark P063 Biochemical and morphological changes in the uterine cervix after pre-treatment with isosorbide mononitrate and misoprostol Nina Vukas Radulovic, Erling Ekerhovd, Anders Norström Sahlgrenska Universitetssjukhus, GÖTEBORG, Sverige P064 The advantage of daily symptom ratings for the diagnosis of menstrual cycle linked conditions Sigrid Nyberg1, Stefan Hammarbäck2, Marie Bixo2, Inger Sundström-Poromaa3, Torbjörn Bäckström2 1Norrlands Universitetssjukhus, UMEÅ, Sverige 2Inst Clinical Science, obstetrics and gynecology, UMEÅ, Sweden 3Inst of Women`s and Children`s Health, UPPSALA, Sweden P065 Association of Interleukin-10 Promoter Polymorphism with Endometriosis Mads Riiskjaer1, Kaspar Nielsen2, Rudi Steffensen2, Christian Erikstrup1, Axel Forman1, Christina Kruse1 1Aarhus University Hospital, Skejby, AARHUS N, Denmark 2Aarhus University Hospital, AALBORG, Denmark P066 Decreased blood flow in left medial prefrontal and right striatal areas correlates to increased self-rated fatigue in women with premenstrual dysphoria Olle Eriksson1, Tord Naessén2, Anders Wall3, Gunnar Blomqvist3, Bengt Långström3, Anton Forsberg4, Ina Marteinsdottir5, Hans Ågren6, Per Hartvig7 1Women´s and Children´s health/ObGyn, UPPSALA, Sweden 2Department of Women´s and Children´s health, UPPSALA, Sweden 3Uppsala Imanet, GE Healthcare, UPPSALA, Sweden 4Department of Neurology, Karolinska Institutet, STOCKHOLM, Sweden 5Department of Neuroscience, Section of Psychiatry, Akademiska sjukhuset, UPPSALA, Sweden 6Department of Clinical Neuroscience, Section of Psychiatry at Huddinge, K.I., STOCKHOLM, Sweden 7Hospital Pharmacy, AKADEMISKA SJUKHUSET, Sweden P067 Difference in hormonal levels between lean and overweight women with PCOS Thilde Sangild Villemann, Birgitta Trolle Aarhus University Hospital Skejby, ÅRHUS V, Denmark

NFOG 2008 27 P068 Metabolic characteristics/features of first degree relatives of women with polycystic ovary syndrome Assi Torvinen1, Riitta Koivunen2, Anneli Pouta3, Stephen Franks4, Hannu Martikainen5, Aini Bloigu3, Anna-Liisa Hartikainen5, M.I. McCarthy6, Aimo Ruokonen7, M-R. Järvelin8, Laure Morin-Papunen5 1Oulu University, OULU, Finland 2Family Federation of Finland, OULU, Finland 3Dept. of Public Health Science and General Practice, UNIVERSITY OF OULU, Finland 4Institute of Reproductive and Developmental Biology, Imperial College, LONDON, United Kingdom 5Dept. of Obstetrics and Gynaecology, UNIVERSITY HOSPITAL OF OULU, Finland 6Oxford Centre for Diabetes, Endocrinology and Metabolism, OXFORD, United Kingdom 7Dept. of Clinical Chemistry, UNIVERSITY HOSPITAL OF OULU, Finland 8Dept. of Epidemiology and Public Health, Imperial College, LONDON, United Kingdom P069 The Cost-Effectiveness of estradiol 0.5 mg /norethisterone acetate 0.1 mg for Swedish Women with an Intact Uterus and Menopausal Symptoms Ann-Sofie Brandt1, Oskar Ström2, Dorothea Koeppe-Utelli3, Vicki Munro1 1Novo Nordisk, CRAWLEY, United Kingdom 2i3 Innovus, STOCKHOLM, Sweden 3Novo Nordisk Region Europe A7S, ZURICH, Switzerland P070 Hormone Therapy modulates ETA mRNA expression in the aorta of ovariectomized New Zealand White Rabbits Susan Pedersen1, Lars Bo Nielsen2, Nina Gros Pedersen3, Lisbeth Nilas4, Bent Ottesen3 1Hilleroed Hospital, HILLEROED, Danmark 2Dept. of Clinical Biochemistry, Copenhagen University Hospital, COPENHAGEN, Danmark 3The Juliane Marie Centre, Copenhagen University Hospital, COPENHAGEN, Danmark 4Dept. of Obstetrics and Gynaecology, Hvidovre University Hospital, HVIDOVRE, Danmark P071 A longitudinal study of contraception in the same women, born in 1962, followed over a quarter of a century Ingela Lindh, Agneta Andersson-Ellström, Febe Blohm, Ian Milsom Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, GÖTEBORG, Sweden P072 Age, parity, and contraceptive choices affect the risk of repeated abortion Oskari Heikinheimo1, Mika Gissler2, Satu Suhonen3 1Univ of Helsinki, HELSINKI, Finland 2National Research and Development Centre for Welfare and Health, HELSINKI, Finland 3Dept Ob&Gyn, Univ of Helsinki, HELSINKI, Finland P073 Satisfaction with contraceptive services and contraceptive behaviour in Estonia, Russia and Finland Made Laanpere1, Tatiana Dubikaytis2, Minna Nikula3, Kai Part1, Kai Haldre1, Elina Hemminki3, Helle Karro1 1University of Tartu, TARTU, Estonia 2St. Petersburg Medical Academy of Postgraduate Studies, ST. PETERSBURG, Russian Federation 3National Research and Development Centre for Welfare and Health, HELSINKI, Finland P074 Is the use of reliable contraceptive methods associated with contraceptive service type? Kai Part1, Kaja Rahu2, Made Laanpere1, Kai Haldre1, Mati Rahu2, Helle Karro1 1University of Tartu, TARTU, Estonia 2National Institute for Health Development, TALLINN, Estonia P075 Prevalence of psychiatric disorders and premenstrual symptoms in patients with ongoing or prior experience of adverse mood during treatment with combined oral contraceptives Birgitta Segeblad Uppsala Universtity, UPPSALA, Sweden P076 Does smoking affect the result of treatment for urinary incontinence? Rikke Guldberg1, Torsten Sorensen2 1Kolding Hospital, FREDERICIA, Danmark 2Kolding hospital, KOLDING, Danmark

28 NFOG 2008 P077 Pelvic floor muscle training in the prevention and treatment of urinary incontinence in women – what is the evidence? A systematic review Søren Brostrøm, Gunnar Lose Glostrup Hospital, GLOSTRUP, Danmark P078 Nocturia in relation to sleep quality in an unselected population of women and men aged 60–80 years in Denmark Mette Hornum Bing, Poul Jennum, Lars Alling Møller, Svend Mortensen, Gunnar Lose Glostrup Hospital, GLOSTRUP, Denmark P079 Risk factors for complications with the TVT-procedure Kjell Schedvins1, Elsa Ryde-Blomqvist2 1Karolinska University Hospital, STOCKHOLM, Sverige 2PSR, STOCKHOLM, Sweden P080 The effect of hysterectomy or LNG-IUS on wellbeing – A 5-year randomised controlled trial Satu Heliövaara-Peippo1, Karoliina Halmesmäki1, Ritva Hurskainen2, Juha Teperi3, Seija Grenman4, Aarre Kivelä5, Erkki Kujansuu6, Marjo Tuppurainen7, Merja Yliskoski8, Sirkku Vuorma9, Jorma Paavonen2 1University of Helsinki, HELSINKI, Finland 2Department of Obstetrics and Gynecology, University of Helsinki, HELSINKI, Finland 3Health Services Research Unit, STAKES, HELSINKI, Finland 4Department of Obstetrics and Gynecology, University of Turku, TURKU, Finland 5Department of Obstetrics and Gynecology, University of Oulu, OULU, Finland 6Department of Obstetrics and Gynecology, University of Tampere, TAMPERE, Finland 7Department of Obstetrics and Gynecology, University of Kuopio, KUOPIO, Finland 8Central Hospital of Central Finland, JYVÄSKYLÄ, Finland 9National Public Health Institute, HELSINKI, Finland P081 Introduction of bipolar hysteroscopic transcervical endometrial resection (TCER) in a rural hospital in Iceland Vilhjálmur Kr. Andrésson1, Lýður Ólafsson1, Olav Istre2 1Akranes hospital and general healtcare center, AKRANES, Iceland 2Ulleval University Hospital, OSLO, Norway P082 Intravenous Tranexamic Acid And Total Abdominal Hysterectomy: A Prospective Randomized Study Rikke Guldberg1, Andersen Bent2 1Kolding Hospital, FREDERICIA, Danmark 2Kolding hospital, KOLDING, Danmark P083 The treatment of Bartholin´s cyst or abscess with silver nitrate Pinar Bor, Niels Ole Knoblauch, Inger Stornes Randers Hospital, RANDERS, Danmark P084 Long-term outcome following radical surgery for rectovaginal endometriosis (RVE) Satu Tarjanne, Jari Sjöberg, Oskari Heikinheimo Helsinki University Hospital, HELSINKI, Finland P085 Posterior intravaginal slingplasty sling versus unilateral sacrospinous ligament fixation in treatment of severe vaginal vault prolapsea Virva Nyyssönen1, Anne Talvensaari-Mattila2, Markku Santala2 1North Carelian Central Hospital, JOENSUU, Finland 2Oulu University Hospital, OULU, Finland P086 The Essure transcervical sterilisation procedure, a review of case series Marie-Louise Saaby, Søren Stampe Sørensen Glostrup Hospital, GLOSTRUP, Danmark P087 Uterine vascular malformation after elective termination of pregnancy. A case report Maija-Riitta Ordén, Petri Sipola, Anu Ruuskanen, Hannu Manninen Kuopio University Hospital, KUOPIO, Finland

NFOG 2008 29 P088 Medical abortion in Iceland - experience from the first 246 treatments Ágúst Ingi Ágústsson, Jens A. Guðmundsson, Kristín Jónsdóttir Landspitali University Hospital, REYKJAVIK, Iceland P089 Cytology quality in the national cervical screening program in Slovenia Leon Meglic, Andrej Mozina, Stelio Rakar University Clinical Center, LJUBLJANA, Slovenia P090 Human Papillomavirus persistence after treatment for cervical dysplasia with conization and laser vaporisation Lennart Kjellberg University of Umeå, UMEÅ, Sweden P091 HPV- testing of women aged 30 and above with the diagnosis ASC-US/LSIL cervical cytology in the Copenhagen population screening programme for cervical cancer Benny Kirschner1, Kåre Simonsen2, Jette Junge2 1Herlev Hospital, COPENHAGEN, Danmark 2Dep. of pathology, Hvidovre Hospital, COPENHAGEN, Denmark P092 Evaluation of tampon as a suitable self sampling device for detection of HPV mRNA from cervical cells – a preliminary report Hanne Skomedal1, Runi Rogers1, Greta Dreyer2 1NorChip AS, KLOKKARSTUA, Norge 2University of Pretoria, PRETORIA, South Africa P093 Increased MMP-2, MMP-9 and TIMP-2 expression is associated with progression from VIN to invasive vulvar carcinoma Anne Talvensaari-Mattila, Milla Määttä, Ylermi Soini, Taina Turpeenniemi-Hujanen, Markku Santala Oulu University, OULU, Finland P094 ‘Complications after extensive surgery for epithelial ovarian cancer FIGO stage IIIC and IV in a Nordic Centre. Experiences from the first nine months’ Kirsten Jochumsen, Ole Mogensen Odense University Hospital, ODENSE C, Denmark P095 GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors Mikko Anttonen1, Antti Kyrönlahti2, Leila Unkila-Kallio3, Ralf Butzow4, Arto Leminen3, Ilpo Huhtaniemi5, Markku Heikinheimo2 1University of Helsinki, HELSINKI, Finland 2Children's Hospital and Program for Women's Health, University of Helsinki, HELSINKI, Finland 3Department of Obstetrics and Gynecology, University of Helsinki, HELSINKI, Finland 4Department of Pathology, University of Helsinki, HELSINKI, Finland 5Department of Reproductive Biology, Imperial College London, LONDON, United Kingdom P096 Vascular endothelial growth factor in granulosa cell tumors Anniina Färkkilä1, Antti Kyrönlahti1, Leila Unkila-Kallio2, Ralf Butzow3, Markku Heikinheimo1, Mikko Anttonen1 1Children's Hospital and Program for Women's Health, University of Helsinki, HELSINKI, Finland 2Department of Obstetrics and Gynecology, Helsinki University Central Hospital, HELSINKI, Finland 3Department of Pathology, Helsinki University Central Hospital, HELSINKI, Finland P097 The tumor suppressors p53, p27 and p21, their relationship and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma Ingiridur Skírnisdóttir1, Katarina Lindborg1, Bengt Sorbe2, Tomas Seidal3 1Department of Women’s and Children’s Health, Obstetrics and Gynecology, Akadem, UPPSALA, Sweden 2Department of Gynecological Oncology, Örebro University Hospital, Örebro, ÖREBRO, Sverige 3Department of Pathology, Halmstad Medical Center Hospital, HALMSTAD,, Sweden

30 NFOG 2008 P098 Simulation based Team Training as a Tool to Improve Patient Safety and Communication Skills Marlene Mohr1, Doris Oestergaard2, Morten Lebech3, Henriette Hintz3, Nini Vallebo2, Anette Lewkovitch3, Berit Woetmann Petersen4, Kurt Nielsen5 1University hospital in Herlev, Copenhagen, HERLEV, Denmark 2Danish institute for Medical Simulation, HERLEV, COPENHAGEN, Denmark 3Department og Gynaecology and Obstetrics, HERLEV, Denmark 4Depertment of Gynaecology and Obstetrics, Rigshospitalet, COPENHAGEN, Denmark 5Department of Anaestesiology, ROSKILDE, Denmark P099 Retention of Skills in Procedural Laparoscopic Virtual Reality Simulator Training Mathilde Maagaard1, Jette Led Soerensen1, Torur Dalsgaard2, Bent Ottesen1, Teodor P Grantcharov3, Christian Rifbjerg Larsen1 1Rigshospitalet, COPENHAGEN Ø, Denmark 2Rigshopitalet, COPENHAGEN, Denmark 3St Michael´s hospital, TORONTO, Canada P100 An Observational Crossover Comparison of Specialist Training in Obstetrics and Gynaecology in Great Britain and Denmark Morten Beck Sorensen West Middlesex University Hospital, LONDON, United Kingdom

NFOG 2008 31 Monday June 16th

08:15–09:00 IS-029 Plenary lecture: Preeclampsia Main Hall Chair: Alexander Smárason James Walker The University of Leeds, LEEDS, UK

09:00–10:30 Skills training, simulation and assessment II Main Hall Chairs: Juha Mäkinen and Bent Ottesen 09:00–09:25 IS-030 Organization of training and integration of skill training in the curriculum on a local, regional and national level Guylaine Lefebvre Society of Obstetricians and Gynecologists of Canada, TORONTO, Canada 09:25–09:50 IS-031 Simulator training and assessment in laparoscopic gynaecology Christian Rifbjerg Larsen Rigshospitalet, COPENHAGEN, Denmark 09:50–10:15 IS-032 The surgical curriculum; an evidence-based approach Teodor Grantcharov University of Toronto, St. Michael’s Hospital, TORONTO, Canada 10:15–10:30 Discussion

09:00–10:30 Rare serious events in obstetrics Hall 1 Chairs: Lone Krebs and NN 09:00–09:25 IS-033 Eclampsia and Acute Fatty Liver of Pregnancy: The study of rare disorders of pregnancy using the UK Obstetric Surveillance System (UKOSS) Marian Knight National Perinatal Epidemiology Unit, OXFORD, United Kingdom 09:25–09:45 IS-034 European Obstetric Survey System, EUROSS – The Nordic perspective Jens Langhoff-Roos Rigshospitalet, COPENHAGEN Ø, Danmark 09:45–10:10 IS-035 Experiences from a center for pregnant women with heart disease Marianne Johansen The Juliane Marie Centre for Children, Women and Reproduction Copenhagen Univers, COPENHAGEN Ø, Denmark 10:10–10:30 IS-036 Hysterectomy for life-threatening peripartum haemorrhage: Study of a ‘near-miss’ event Marian Knight National Perinatal Epidemiology Unit, OXFORD, United Kingdom

09:00–10:30 Oncology. Free communications III Hall 2 Chairs: Anna Salvarsdóttir and Seija Grénman 09:00–09:10 ON1 Breast cancer risk in postmenopausal women using estrogen-progestin therapy Heli Lyytinen1, Eero Pukkala2, Olavi Ylikorkala1 1Helsinki University Hospital, HELSINKI, Finland 2Finnish Cancer Institute, HELSINKI, Finland

32 NFOG 2008 09:10–09:20 ON2 HPV genotype distribution and E6/E7 mRNA expression in Norwegian women with cervical neoplasia Katrine Dønvold Sjøborg1, Ameli Trope2, Tormod Eriksen3, Vigdis Lauvrak2, Martin Steinbakk2, Morten Jacobsen1, Agnes Kathrine Lie3, Anne Eskild2 1Ostfold Hospital Trust, FREDRIKSTAD, Norway 2Akershus University Hospital, LØRENSKOG, Norway 3Cancer Registry of Norway, OSLO, Norway 09:20–09:30 ON3 Framingham risk score and the metabolic syndrome in epithelial ovarian cancer survivors: a controlled observational study Astrid Helene Liavaag1, Serena Tonstad2, Are H Pripp3, Claes Trope4, Anne Dørum4 1Sørlandets Sykehus, ARENDAL, Norway 2Department of Internal Medicine, Ullevål University Hospital, University of Oslo, OSLO, Norway 3Biostatistics Unit, Research Services Department, Rikshospitalet,, OSLO, Norway 4Department of Gynecological Oncology The Norwegian Radiumhospital , Rikshospital, OSLO, Norway 09:30–09:40 ON4 Gynecological cancer and urinary incontinence Finn Egil Skjeldestad, Bjørn Hagen Institute of laboratory medicine, children- and womens’ diseases, TRONDHEIM, Norway 09:40–09:50 ON5 Treatment for cervical intraepithelial neoplasia and preterm birth Maija Jakobsson1, Mika Gissler2, Jorma Paavonen1, Anna-Maija Tapper1 1Helsinki University Hospital, HELSINKI, Finland 2STAKES National Research and Development Centre for Welfare and Health, HELSINKI, Finland 09:50–10:00 ON6 Human Papillomavirus infection is associated with increased cervical nitric oxide release in the human uterine cervix Päivi Rahkola, Tomi Mikkola, Pekka Nieminen, Olavi Ylikorkala, Mervi Väisänen-Tommiska Helsinki University Central Hospital, Finland, HELSINKI, Finland

09:00–10:30 Medical abortion Hall 3 Chairs: Kevin Sunde Oppegaard and Per Lundorff 09:00–09:15 IS-037 Cervical ripening Helena Hertzen von World Health Organization, GENEVA, Switzerland 09:15–09:30 IS-038 Contraception after abortion Oskari Heikinheimo Helsinki University Hospital, HELSINKI, Finland 09:30–09:45 IS-039 Medical abortion in late first trimester (9–12 w) Ole Erik Iversen Haukeland Universitetssykehus, BERGEN, Norway 09:45–10:00 IS-040 Medical abortion in very early pregnancy Christian Fiala Gynmed Clinic, VIENNA, Austria 10:00–10:15 IS-041 Home-use of misoprostol in medical abortion Kristina Gemzell Danielsson Karolinska Institutet, STOCKHOLM, Sverige 10:15–10:30 Discussion 10:30–11:00 Coffee Break / Exhibition

11:00–12:30 Hormone treatment in the climateric – options for today and tomorrow Main Hall Chairs: Lars Åke Mattsson and Päivi Polo 11:00–11:25 IS-042 Is there a ‘window of opportunity’ Göran Samsioe Lund university Hospital, LUND, Sweden

NFOG 2008 33 11:25–11:50 IS-043 Alternative treatment from an evidence based perspective Mette Haase Moen St Olavs University Hospital, TRONDHEIM, Norway 11:50–12:15 IS-044 Guidelines for HT from an International perspective Sven O. Skouby University of Copenhagen, COPENHAGEN, Denmark 12:15–12:30 Discussion

11:00–12:30 Severe maternal hemorrhage Hall 1 Chairs: Birgit Bødker and Knud Hordnes :00–11:45 IS-045 Pathophysiology of severe PPH and general management Jouni Ahonen Maternity Hospital, Helsinki University Hospital, HELSINKI, Finland 11:45–12:05 IS-046 Placenta Accreta Adam Borgida Hartford Hospital, CONNECTICUT, USA 12:05–12:30 IS-047 New methods in treating severe postpartum hemorrhage (PPH) Kjell Salvesen National Center for Fetal Medicine, TRONDHEIM, Norway

11:00–12:30 Fetal surveillance. Free communications IV Hall 2 Chairs: Jens Langhoff-Roos and NN 11:00–11:10 FS1 Acidaemia at birth related to management of the last two hours of labour Maria Jonsson1, Solveig Nordén Lindeberg1, Ingrid Östlund2, Ulf Hanson1 1Department of Women’s and Children’s Health Uppsala University Uppsala, UPPSALA, Sweden 2Deparment of Obstetrics and Gynecology, ÖREBRO, Sweden 11:10–11:20 FS2 Evaluation and impact of CTG training programmes Caroline Pehrson1, Jette Led Soerenson2, Isis Amer-Wåhlin3 1Sygehus Syd Næstved, NÆSTVED, Danmark 2Obstetric Department and Juliane Marie Centre, Rigshospitalet, COPENHAGEN, Danmark 3Department of Women and Child Health, Karolinska University Hospital, STOCKHOLM, Sverige 11:20–11:30 FS3 Neonatal resuscitation of asphyctic infants due to obstetrical malpractice in conjunction with labour in Sweden 1990–2005 Sophie Berglund1, Mikael Norman2, Charlotta Grunewald1, Hans Pettersson1, Sven Cnattingius3 1ADepartment of Clinical Science and Education, Södersjukhuset, Karolinska Instit, STOCKHOLM, Sweden 2Department for Clinical Science, Intervention and Technology,, STOCKHOLM, Sweden 3Department of Medical Epidemiology and Biostatistics,, STOCKHOLM, Sweden 11:30–11:40 FS4 Obstetricians’ choice of delivery method in ambiguous cases: Is it influenced by risk attitude? Dorthe Fuglenes1, Pål Øian2, Ivar Sønbø Kristiansen3 1University of Oslo, OSLO, Norway 2Department of Obstetrics and Gynecology, University Hospital of North Norway, TROMSØ, Norway 3Institute of Health Management and Health Economics, University of Oslo, OSLO, Norway 11:40–11:50 FS5 Implementation of new intra partum fetal monitoring in a Danish Hospital: Impact on the rate of operative delivery and neonatal outcome Isis Amer-Wåhlin1, Heidi Fosgrau Sharif2, Kristine Sylvan Andersen2, Thomas Bergholt3, Morten Hedegaard4 1Karolinska Institute, SOLNA, Sweden 2Obstetric Clinic, Juliane Marie Center,Rigshospitalet, Copenhagen University, COPENHAGEN, Denmark 3Department of Obstetrics and Gynecology, Hillerod Hospital, CopenhagenUniversity, COPENHAGEN, Denmark 4Juliane Marie Center, Rigshospitalet, COPENHAGEN, Denmark

34 NFOG 2008 11:50–12:00 FS6 Clinical experience with CTG and ST analysis of the fetal electrocardiogram – low cord metabolic acidosis rate at a tertiary care centre Jørg Kessler, G Midbøe, T Hahn, F Macsali, E Wik, S Albrechtsen Haukeland University Hospital, BERGEN, Norway 12:00–12:10 FS7 ST analysis and prevention of hypoxia – the Turku experience Susanna Timonen Turku University Hospital, TURKU, Finland 12:10–12:20 FS8 Adverse outcome in relation to use of STAN Isis Amer-Wåhlin1, Branka Yli2, Håkan Norén3 1Karolinska Institute, SOLNA, Sweden 2Department of Obstetrics and Gynaecology, Rikshospitalet, University of Oslo, OLSO, Norway 3Department of Gynaecology, Perinatal Center, Sahlgrenska University Hospital, GÖTEBORG, Sweden 12:20–12:30 FS9 Fetal monitoring with CTG in combination with ST analysis vs. CTG alone – a cost- effectiveness analysis Emelie Heintz1, Thor-Henrik Brodtkorb1, Nina Nelson2, Lars-Åke Levin1 1Center for Medical Technology Assessment, LINKÖPING, Sweden 2Division of Paediatrics, Linköping University Hospital, LINKÖPING, Sweden

11:00–12:30 Contraception Hall 3 Chairs: Elof Johansson and Runa Aabø 11:00–11:20 IS-048 The changing panorama of contraceptive use in the Nordic countries Ian Milsom Institute of Clinical Sciences, Sahlgrenska Academy, Göteborg University, GÖTEBORG, Sweden 11:20–11:40 IS-049 The use of LNG-IUS in nulliparous women Satu Suhonen Helsinki City, HELSINKI, Finland 11:40–12:00 IS-050 Menstrual cycle suppression. An endocrine treatment and a modern solution to a modern problem Leslie Miller University of Washington, SEATTLE, USA 12:00–12:20 IS-051 Hormonal contraception and risk of venous thromboembolism. Dose reduction matters Øjvind Lidegaard Rigshospitalet, COPENHAGEN Ø, Danmark 12:20- 12:30 Discussion

12:30–14:00 Lunch symposium – sponsored by Sanofi Pasteur MSD Latest Clinical Update on GARDASIL® Hall 1

12:30–12:35 Opening Introduction Assoc. Professor Cecilia Young 12:35–12:55 GARDASIL® (Quadrivalent HPV Vaccine) An Update with 4 years Clinical Efficacy Data Nubia Munoz – M.D. MPH 12:55–13:05 Discussion 13:05–13:25 Benefits of GARDASIL® – On Ohter HPV types – In women above 25 years Professor Ole Erik Iversen M.D. 13:25 Discussion and Closure

NFOG 2008 35 12:30–14:00 Lunch symposium – sponsored by Renapharma Postpartum anemia – what is the optimal treatment? Hall 2

Erythropoiesis during pregnancy Ivor Cavill, CARDIFF, United Kingdom IV iron vs oral iron Results of the Norwegian Multicenter Study Stian Westad, LILLEHAMMER, Norway IV ferric carboxymaltose Results of the American Multicenter Study Tom Goodnough, STANFORD, CAL, USA Blood transfusion? No, thank you! Ivor Cavill, CARDIFF, United Kingdom

12:30–14:00 General Assembly Hall 4 Chair: Peter Hornnes

14:00–14:45 Plenary: Should we discontinue public funding of assisted reproduction? Main Hall Chair: Helle Meinertz IS-052 Why are European laws on reproduction so similar? Paul Devroey Centre for Reproductive Medicine, BRUSSELS, Belgium IS-053 It is a mistake to limit public funding of assisted reproduction Johannes Evers Maastricht University Medical Center, MAASTRICHT, Nederland

14:45–16:15 Genetic medicine Main Hall Chairs: Hildur Harðardóttir and Thue Bryndorf 14:45–15:15 IS-054 Genetic counselling: psychosocial issues and decision making Heather Skirton University of Plymouth, TAUNTON, United Kingdom 15:15–15:45 IS-055 Heritable gynecological cancer Anne-Marie Gerdes Odense University Hospital, ODENSE C, Danmark 15:45–16:15 IS-056 Combined risk assessment for fetal aneuploidy with nuchal translucency and biochemical markers. The Danish experience, before and after the guidelines from Sundhedsstyrelsen Ann Tabor Copenhagen University Hospital, Rigshospitalet, COPENHAGEN Ø, Danmark

14:45–16:15 Fear of childbirth – what is it about and what can we do? Hall 1 Chairs: Charlotta Grunewald and Jukka Uotila 14:45–15:05 IS-057 Depression and anxiety during pregnancy – prevalence and obstetric outcome Liselott Andersson Sunderby hospital, LULEÅ, Sweden 15:05–15:25 IS-058 Violence against women may influence childbirth Berit Schei NTNU, TRONDHEIM, Norge

36 NFOG 2008 15:25–15:45 IS-059 Fear of childbirth and the wish for a caesarean Elsa Lena Ryding Karolinska University Hospital, STOCKHOLM, Sweden 15:45–16:05 IS-060 Fear of childbirth can be treated and cesarean section avoided Terhi Saisto Helsinki Univeristy Central Hospital, HUS (HELSINKI), Finland 16:05–16:15 Discussion

14:45–16:15 Symposium – sponsored by Bayer Schering Pharma New research: Important data for counseling your OC patients Hall 2 Bayer Schering Pharma: Taking a leading role in woman's health research Chair: Maureen Cronin EURAS: The largest European active surveillance study on the safety and efficacy of OC use Juergen Dinger, Germany Health Authority representative: Steinar Madsen, Norway New major studies on the protective effect of OC use on ovarian and endometrial cancer Ian Milsom, Sweden Putting the new data into perspective for your OC patients Maureen Cronin, (Bayer Schering Pharma), Germany

14:45–16:25 Presentation of theses Hall 3 Chairs: Lars-Åke Mattsson and Knut Hordnes 14:45–15:05 IS-061 Diet and lifestyle of women of childbearing age – Impact of cod liver oil consumption on maternal health, birth outcome and breast milk composition and associations between diet, lifestyle and weight gain in pregnancy Anna S Olafsdottir Iceland University of Education, REYKJAVÍK, Iceland 15:05–15:25 IS-062 Primary fallopian tube carcinoma: occurrence, risk and prognostic factors Annika Riska Helsinki University Hospital, HELSINKI, Finland 15:25–15:45 IS-063 Biochemical and Epidemiological Studies of Early-Onset and Late-Onset. Pre-Eclampsia Anna-Karin Wikström Uppsala University, Sweden 15:45–16:05 IS-064 Total versus subtotal hysterectomy for benign uterine diseases? Helga Gimbel Hilleroed Hospital, HILLERØD, Denmark 16:05–16:25 IS-065 Portal and umbilical venous distribution in the human fetus Jørg Kessler Haukeland University Hospital, BERGEN, Norway 16:15–16:45 Coffee Break / Exhibition

16:45–18:00 Genetic medicine (cont’d) Main Hall Chairs: Hildur Harðardóttir and Thue Bryndorf 16:45–17:15 IS-066 Prenatal screening for fetal aneuploidy in the first trimester. Nuchal translucency and biochemical markers Adam Borgida Hartford Hospital, CONNECTICUT, USA 17:15–17:45 IS-067 Prenatal screening for structural malformations in the first trimester Hulda Hjartardóttir Landpitali University Hospital, REYKJAVÍK, Iceland

NFOG 2008 37 17:45–18:00 Discussion

16:45–18:00 Preterm birth Hall 1 Chairs: Ulf Höglund and Maija Riitta Ordén 16:45–17:15 IS-068 Pathophysiology of preterm birth Henrik Hagberg Perinatal Center, GÖTEBORG, Sweden 17:15–17:45 IS-069 Clinical management of preterm birth Jan Stener Jørgensen Odense University Hospital, ODENSE, Denmark 17:45–18:00 Discussion

16:45–18:05 Obstetrics – focus on the mother. Free communications V Hall 2 Chairs: Alexander Smárason and Runa Heimstad 16:45–16:55 OM1 Non invasive observation and presentation of the propagation of uterine electrical activity during labor Jeremy TERRIEN1, Helga Medek2, Thora Steingrimsdottir2, Brynjar Karlsson1 1Reykjavik University, REYKJAVIK, Iceland 2Landspitali University Hospital, REYKJAVIK, Iceland 16:55–17:05 OM2 Maintenance Therapy (MT) in Preterm Labour (PTL) – first clinical experiences Britta Frederiksen-Møller1, Jan Stener Jørgensen1, Andreas Herbst2 1Odense University Hospital, ODENSE, Denmark 2Lund University Hospital, LUND, Sweden 17:05–17:15 OM3 Ultrasound measurements or Bishop score before induction of labor? Torbjørn Moe Eggebø1, Inger Økland1, Claudia Heien1, Leif Kaspar Gjessing1, Pål Romundstad2, Kjell Åsmund Salvesen3 1Stavanger University Hospital, STAVANGER, Norway 2Norwegian University of Science and Technology, TRONDHEIM, Norway 3National Center for Fetal Medicine, Trondheim University Hospital (St. Olav’s Ho, TRONDHEIM, Norway 17:15–17:25 OM4 Risk of Cesarean Section after Induction of Labor in Low Risk Women at Term Ole Bredahl Rasmussen1, Pernille Danneskiold Lassen2, Steen Rasmussen3 1Regionshospitalet Randers, RANDERS, Danmark 2Herlev Hospital, HERLEV, Danmark 3National Board of Health, COPENHAGEN, Danmark 17:25–17:35 OM5 Risk indicators for dystocia in nulliparous women Hanne Kjærgaard1, Jørn Olsen2, Bent Ottesen1, Anna-Karin Dykes3 1The Juliane Marie Centre, Rigshospitalet, COPENHAGEN, Denmark 2Department of Epidemiology, School of Public Health, University of California, LOS ANGELES, USA 3Department of Health Sciences, Lund University, LUND, Sweden 17:35–17:45 OM6 Impaired leukocyte influx and high expression of progesterone receptor (PR) and androgen receptor (AR) in postterm failed induction Nathalie Roos, Ylva Vladic-Stjernholm, Lena Sahlin, Masironi Britt, Ekman-Ordeberg Gunvor Karolinska Institutet, STOCKHOLM, Sweden 17:45–17:55 OM7 Postpartum perineal repair performed by midwives: a randomised trial comparing two suture techniques leaving the skin unsutured Sara Kindberg1, Misan Stehouwer2, Lone Hvidman2, Tine Brink Henriksen1 1Perinatal Epidemiology Research Unit, ÅRHUS N., Danmark 2Department of Gynaecology and Obstetrics, AARHUS N., Danmark

38 NFOG 2008 17:55–18:05 OM8 Maternal mortality in Denmark 2002–2006 Birgit Bødker1, Jette Led Sørensen2, Margrethe Møller3, Lone Hvidman4, Tom Weber5 1Hillerød Hospital, HILLERØD, Denmark 2Rigshospitalet University Hospital, COPENHAGEN, Denmark 3Aalborg University Hospital, AALBORG, Denmark 4Aarhus University Hospital, SKEJBY, Denmark 5Hvidovre University Hospital, COPENHAGEN, Denmark

16:45–18:00 New trends in handling male infertility Hall 3 Chairs: Per Olof Janson and Helle Meinertz 16:45–17:10 IS-070 New trends in handling male infertility -Male infertility tests in the era of ICSI. Are genetic tests coming Ulrik Kvist Karolinska institute, STOCKHOLM, Sweden 17:10–17:35 IS-071 Are sperm tests vanishing? Aleksander Giwercman Malmö University Hospital, MALMÖ, Sweden 17:35–18:00 IS-072 Cryopreservation of testicular tissue Claus Yding Andersen1, Erik Ernst2 1University Hospital of Copenhagen, COPENHAGEN, Denmark 2University of Aarhus, AARHUS, Denmark 20:00 Gala dinner

NFOG 2008 39 Tuesday June 17th

09:00–09:45 Plenary: Anatomy of the pelvic floor Main Hall Chair: Jens Guðmundsson IS-073 Anatomy of the pelvic floor Steven Swift Medical University of South Carolina, CHARLESTON, SC, USA

09:45–11:00 Pregnancy, delivery and the pelvic floor Main Hall Chairs: Steingrímur Björnsson and Sophie Berglund 09:45–10:00 IS-074 Epidemiology of female urinary incontinence and prolapse – the impact of pregnancy and delivery Guri Rørtveit University of Bergen, BERGEN, Norway 10:00–10:15 IS-075 Teaching doctors to diagnose and repair perineal lesions Ranee Thakar Mayday University Hospital, CROYDON, United Kingdom 10:15–10:30 IS-076 Teaching midwifes to diagnose and repair perineal lesions Sara Fevre Kindberg Perinatal Epidemiology Research Unit, ÅRHUS N, Danmark 10:30–10:50 IS-077 Obstetrical lesions and the importance of quality of primary repair Abdul Sultan Mayday University Hospital, LONDON, United Kingdom 10:50–11:00 Discussion

09:45–11:00 Pediatric and adolescent gynecology Hall 1 Chairs: Laure Morin-Papunen and Ebba Margrét Magnúsdóttir 09:45–10:05 IS-078 Gynecological examination of children and adolescents Minna Joki-Erkkilä Tampere University Hospital, TAMPERE, Finland 10:05–10:20 IS-079 Chlamydia infection – a worry for the young women or for the gynecologist? Finn Egil Skjeldestad Institute of laboratory medicine, children- and womens’ diseases, TRONDHEIM, Norway 10:20–10:35 IS-080 Trends in adolescent abortion and pregnancy rates in the Nordic countries Dan Apter Väestöliitto, HELSINKI, Finland 10:35–10:50 IS-081 A model for providing contraception and other services for adolescents Lena Marions Karolinska Institutet, STOCKHOLM, Sverige 10:50–11:00 Discussion

09:45–11:00 Premenstrual syndrome/Premenstrual dysphoric disorder Hall 2 Chair: Olle Eriksson and Arnar Hauksson 09:45–10:15 IS-082 Etiology and pathogenesis of PMDD/PMS Torbjörn Bäckström Umeå University Hospital, UMEÅ, Sweden 10:15–10:45 IS-083 Treatment of premenstrual dysphoric disorder Inger Sundström Poromaa Uppsala University, UPPSALA, Sweden 10:45–11:00 Discussion

40 NFOG 2008 09:45–10:55 Obstetrics – focus on the fetus. Free communications VI Hall 3 Chairs: Oskari Heikinheimo and Anna-Karin Wikström 09:45–09:55 OF1 Antenatal corticosteroids in preterm infants Lena Eriksson1, Bengt Haglund2, Helle Kieler3, Viveca Odlind1 1Medical Products Agency, UPPSALA, Sweden 2Socialstyrelsen, STOCKHOLM, Sweden 3Karolinska Institutet, STOCKHOLM, Sweden 09:55–10:05 OF2 Placenta previa – a risk factor for small for gestational age babies. A Danish population based study Lone Nikoline Nørgaard1, Steen Rasmussen2, Thomas Bergholt1 1Hillerød Sygehus, HILLERØD, Denmark 2National Board of Health, COPENHAGEN, Denmark 10:05–10:15 OF3 Systolic myocardial velocity alterations in the growth retarded fetus Lene Unmack Larsen, Olav Bjørn Petersen, Keld Sorensen, Erik Sloth, Niels Uldbjerg Aarhus University Hospital Skejby, AARHUS N, Danmark 10:15–10:25 OF4 Modifiable determinants of fetal macrosomia. Role of life style related factors Nanna Voldner1, Kathrine Froslie1, Kari Bo2, Lene Haakstad2, Camilla Hoff1, Kristin Godang1, Jens Bollerslev1, Tore Henriksen1 1Rikshospitalet Medical Centre, OSLO, Norway 2Norwegian School of Sport Science, OSLO, Norway 10:25–10:35 OF5 Perinatal outcome of children born to mothers with thyroid dysfunction. A prospective population-based cohort study Tuija Männistö1, Marja Vääräsmäki2, Anneli Pouta3, Anna-Liisa Hartikainen2, Aimo Ruokonen4, Heljä- Marja Surcel3, Aini Bloigu3, Marjo-Riitta Järvelin5, Eila Suvanto-Luukkonen2 1University of Oulu, OULU, Finland 2Dept Obstetrics and Gynecology, University of Oulu, OULU, Finland 3National Public Health Institute, OULU, Finland 4Dept Clinical Chemistry, University of Oulu, OULU, Finland 5Dept Epidemiology and Public Health, Imperial College, LONDON, United Kingdom 10:35–10:45 OF6 Danish national controlled cohort study on neonatal outcome of 1267 children born after transfer of cryopreserved IVF and ICSI embryos in 1995 to 2006 Anja Pinborg1, Anne Loft1, Steen Rasmussen2, Anders Nyboe Andersen1 1Rigshospitalet, COPENHAGEN, Denmark 2Danish National Board of Health, COPENHAGEN, Denmark 10:45–10:55 OF7 No correlation between rates of caesarean section and perinatal mortality Guðný Jónsdóttir1, Ragnheiður Bjarnadóttir2, Alexander Smárason3, Reynir Geirsson2 1University Hospital of Iceland, REYKJAVÍK, Iceland 2University hospital of Iceland, REYKJAVÍK, Iceland 3Institution of Health, Sience and Research, University of Akureyri, AKUREYRI, Iceland 11:00–11:30 Coffee Break / Exhibition

11:30–13:00 New technologies in pelvic surgery – what is the evidence? Main Hall Chairs: Søren Broström and Kristín Jónsdóttir 11:30–11:50 IS-084 What is the best sling for stress urinary incontinence Antti Valpas South-Karelian Central Hospital, LAPPEENRANTA, Finland 11:50–12:10 IS-085 The use of implants in surgery for pelvic organ prolapse – evidence or marketing? Daniel Altman Karolinska Institute, Sweden 12:10–12:30 IS-086 Emerging complications with novel technologies in pelvic surgery Eckhard Petri Helios-Clinics, SCHWERIN, Germany

NFOG 2008 41 12:30–12:50 IS-087 Scientific, ethical and legal implications of introducing new technologies in pelvic surgery Gunnar Lose Glostrup County Hospital, GLOSTRUP, Denmark 12:50–13:00 Discussion

11:30–12:55 Polycystic ovarian syndrome Hall 1 Chairs: Per-Olof Janson and Anette Tønnes Pedersen 11:30–11:40 IS-088 Introduction Jens A. Guðmundsson University Hospital of Iceland, REYKJAVÍK, Iceland 11:40–12:05 IS-089 ‘In utero veritas’ – Fetal intrauterine androgen exposure and PCOS Sven M. Carlsen Institute of Laboratory Medicine, Children`s and Women`s Health, TRONDHEIM, Norway 12:05–12:30 IS-090 The fertility aspects of PCOS Laure Morin-Papunen University of Oulu, OULU, Finland 12:30–12:55 IS-091 When pregnant, then what? Eszter Vanky Inst of laboratory medicine, childrens and womens health, TRONDHEIM, Norway

11:30–13:00 Postterm pregnancies Hall 2 Chairs: Thomas Bergholt and Leea Keski-Nisula 11:30–11:50 IS-092 Induction of post term pregnancy – time to reconsider? Ole Jakob Nakling Sykehuset Innlandet Lillehammer, LILLEHAMMER, Norway 11:50–12:10 IS-093 Routine induction of labour at 41 weeks gestation: Nonsensus Consensus Kåre Augensen Haukeland University Hospital, BERGEN, Norway 12:10–12:30 IS-094 Management of post-date pregnancy: Todays’ evidence Ulla-Britt Wennerholm Dep Ob Gyn, GÖTEBORG, Sweden 12:30–12:50 IS-095 Induction of labour or serial antenatal fetal monitoring in post-term pregnancy. A randomised controlled trial Runa Heimstad St.Olavs Hospital, University Hospital, Trondheim, TRONDHEIM, Norway 12:50–13:00 Discussion

11:30–13:00 Gynecology. Free communications VII Hall 3 Chairs: Jóhannes Guðmundsson and NN 11:30–11:40 GY1 Complications following female sterilization in Sweden 1976–2003 Louise Thunell1, Elsa Ryde-Blomqvist2, Viveca Odlind3, Ian Milsom4 1Department of Obstetrics and Gynecology, Malmö University Hospital, MALMÖ, Sweden 2The County Council´s Mutual Insurance Company (LÖF), STOCKHOLM, Sweden 3The Medical Products Agency, UPPSALA, Sweden 4The Department of Obstetrics and Gynecology, Sahlgrenska Academy, GOTHENBURG, Sweden 11:40–11:50 GY2 Vaginal misoprostol vs placebo before hysteroscopy Kevin Oppegaard Helse Finnmark, HAMMERFEST, Norway

42 NFOG 2008 11:50–12:00 GY3 Factors associated with endometrial polyps in a Danish population Eva Dreisler, Søren Stampe Sørensen, Gunnar Lose Glostrup Hospital, University of Copenhagen, GLOSTRUP, Denmark 12:00–12:10 GY4 To avoid adhesion occlusion – Ethicon Intercoat is the solution Per Lundorff Region Hospital Viborg, VIBORG, Danmark 12:10–12:20 GY5 The treatment of a tub-ovarian abscesses is usually antibiotics and surgery: What about ultrasound guided drainage? Seth Granberg1, Erling Ekerhovd, MD., Ph.D.2, Knut Gjelland, MD3 1Dept OB GYN, Karolinska Univ. Hospital, Kvinnokliniken, Akershus Univ. Sjukhus, STOCKHOLM, Sweden 2Depart of Obstet and Gynecol, Sahlgrenska University Hospital, GOTHENBURG, Sweden 3Depart. of Obstet. and Gynecol., Bergen University, BERGEN, Norway 12:20–12:30 GY6 A Danish National survey on subjective cure, satisfaction and complications 4 years after Tension free Vaginal Tape (TVT) Astrid Ammendrup, Pia Sander, Gunnar Lose Glostrup Hospital, GLOSTRUP, Danmark 12:30–12:40 GY7 Tension-free Vaginal Tape (TVT) versus Tension-free Vaginal Tape-Obturator (TVT-O) – one year follow-up results of Randomized Clinical Trial Antti Valpas1, Pauliina Aukee2, Aarre Kivelä3, Eija Laurikainen4, Kirsi Rinne5, Teuvo Takala6, Carl-Gustaf Nilsson7 1South-Karelian Central Hospital, LAPPEENRANTA, Finland 2Central-Finland Central Hospital, JYVÄSKYLÄ, Finland 3Oulu University Hospital, OULU, Finland 4Turku University Hospital, TURKU, Finland 5Kuopio University Hospital, KUOPIO, Finland 6Päijät-Häme Central Hopital, LAHTI, Finland 7Helsinki University Central Hospital, HELSINKI, Finland

13:00 Closing ceremony. Prizes awarded for best presentations Main Hall Refreshments

NFOG 2008 43